Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-05T04:58:07.707Z Has data issue: false hasContentIssue false

Fatal outbreaks of jaundice in pregnancy and the epidemic history of hepatitis E

Published online by Cambridge University Press:  25 January 2012

C.-G. TEO*
Affiliation:
Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, USA
*
*Address for correspondence: Dr C.-G. Teo, Division of Viral Hepatitis, Centers for Disease Control and Prevention, Mailstop A33, 1600 Clifton Road, Atlanta, GA 30333, USA. (Email: [email protected])
Rights & Permissions [Opens in a new window]

Summary

Space–time clustering of people who fall acutely ill with jaundice, then slip into coma and death, is an alarming phenomenon, more markedly so when the victims are mostly or exclusively pregnant. Documentation of the peculiar, fatal predisposition of pregnant women during outbreaks of jaundice identifies hepatitis E and enables construction of its epidemic history. Between the last decade of the 18th century and the early decades of the 20th century, hepatitis E-like outbreaks were reported mainly from Western Europe and several of its colonies. During the latter half of the 20th century, reports of these epidemics, including those that became serologically confirmed as hepatitis E, emanated from, first, the eastern and southern Mediterranean littoral and, thereafter, Southern and Central Asia, Eastern Europe, and the rest of Africa. The dispersal has been accompanied by a trend towards more frequent and larger-scale occurrences. Epidemic and endemic hepatitis E still beset people inhabiting Asia and Africa, especially pregnant women and their fetuses and infants. Their relief necessitates not only accelerated access to potable water and sanitation but also vaccination against hepatitis E.

Type
Historical Review
Creative Commons
This is a work of the U.S. Government and is not subject to copyright protection in the United States.
Copyright
Copyright © Cambridge University Press 2012 This is a work of the U.S. Government and is not subject to copyright protection in the United States.

Introduction

The year 1858 was marked in Martinique by the appearance of an epidemic of jaundice.

O. Saint-Vel, 1862 [Reference Saint-Vel1]

So begins Saint-Vel's account of a strange disease that visited the French Caribbean colony. Striking first at St Pierre in April [Reference Ballot2], it then spread across the island, and by the end of the year, left 24 people dead, all women [Reference Saint-Vel1]. At the garrison in nearby Fort-de-France, none of the jaundiced soldiers perished [Reference Decaudin3]. Reflecting on the epidemic's alarming propensity to kill women, Saint-Vel's contemporary in Paris, Hervieux, averred: ‘there was a severe form, always the same, always fatal: the comatose form’ [Reference Hervieux4]. The risk factor for fatality was not just being female, but being pregnant: for that was the condition of 20 of the dead.

The epidemic in Martinique was among the earliest of its kind recorded. Might it have been hepatitis E – a transmissible, jaundice-engendering disease that can not only take on epidemic proportions but also generate excess cases of hepatic coma and death in gestational women? This review examines outbreaks of jaundice that have especially imperilled the pregnant, assessing if those occurrences may be, or are – in fact – hepatitis E.

Literature search

Monographs published in the 19th century which describe diseases that cause epidemics of acute jaundice were consulted for discussion of outbreaks notable for deaths in pregnant women. Reports cited in the key monographs [Reference Decaudin3, Reference Ozanam5Reference Vinay7] were accessed. The terms ‘jaundice’, ‘yellow atrophy’, ‘liver necrosis’, ‘outbreak’, ‘epidemic’, ‘pregnant’ and ‘women’, in various combinations, were searched among titles, abstracts, or both, in: Tropical Diseases Bulletin; Bulletin of Hygiene; Journal of the American Medical Association including its Current Medical Literature section of volumes 32–144 (1899–1950); The Lancet; British Medical Journal; Transactions of the Royal Society of Hygiene and Tropical Medicine; and the Quarterly Journal of Medicine. These terms were also searched using PubMed. Primary articles thought pertinent were then sourced for review.

Early epidemics

Since the 18th century when epidemics of jaundice started being documented [Reference Ozanam5], two earlier outbreaks were noted for leading pregnant women into coma, then death. One cluster occurred in Ludenscheid in the Palatinate (1794) [Reference Kerksig8] and the other in Roubaix, France (1852–1854) [Reference Carpentier9]. Neither was as devastating as what Saint-Vel witnessed. Two subsequent epidemics in France, which struck Limoges (1859) [Reference Bardinet10] and Paris (1871) [Reference Decaudin3, Reference Hervieux11], wherein fatalities were observed only among gestating (and to a lesser extent, parturient and postpartum) women, alerted continental physicians to the possibility that certain jaundice epidemics could in the course of hitting the population at large put pregnant women at especial risk of death [Reference Vinay7]. A comment by Ollivier (1873) typifies such wonderment:

It is remarkable that in epidemics of jaundice that spontaneously develop in a city or a small region, we see quite often a disease become serious in pregnant women, whereas it was benign in other women [Reference Ollivier13].

Deaths were not confined to the mothers. In Martinique, almost all of the dead women delivered stillborn infants [Reference Saint-Vel1]. Other outbreaks generated high rates of premature delivery, miscarriages and stillbirths not only among the dead but the survivors also. Thus, in Limoges, there were six stillbirths compared to three maternal deaths [Reference Bardinet10]; and in Paris, although of the 16 cases only two died, ten aborted spontaneously or delivered prematurely [Reference Vinay7].

In the Paris outbreak of 1871 [Reference Decaisne12], pregnant case-patients were admitted to La Maternité, the lying-in hospital for the city's poor [Reference Decaudin3, Reference Vinay7, Reference Hervieux11]. Autopsies conducted there to identify the causes of maternal and infant mortality [Reference Fuchs14] attributed the demise of the jaundiced women to acute yellow atrophy. This term had been introduced some three decades before to describe the striking yellow and shrunken appearance at post-mortem of the melting liver, during which it is ‘drowned in the bilious deliquescence, and disappears’ [Reference Wickham Legg6]. Such a vivid morbid entity, correlating microscopically with massive necrosis of the hepatic parenchyma, became associated with a puzzling disorder occasionally encountered in acutely jaundiced patients whereupon coma would supervene, advancing to death, the extent of overt haemorrhage being variable. An over-representation of pregnant women (up to a third) had begun to be noted in case-series studies of patients who died from the condition [Reference Decaudin3, Reference Wickham Legg6, Reference Vinay7] but not until the La Maternité outbreak was it linked directly to fatalities arising from an epidemic.

As the 19th century progressed, four more space–time clusters of jaundice epidemics bearing similar predilections for pregnant women were reported, albeit small in scale compared to the Martinique outbreak. One occurred in Heusenstamm, Germany (1874) [Reference Klingelhoeffer15] and the others in more dispersed localities: St Paul, Minnesota (1874) [Reference Smith16] and an unspecified village in Tennessee (1898) [Reference Young17], the USA; and also Brisbane, in Queensland (1888) [Reference Hardie18]. Only in the Brisbane outbreak were autopsies performed, the livers of four of the five women being found shrunken and rhubarb-yellow. Over the same period in Australia, two other clusters, located in Sydney, were observed in which pregnant women were the most severely affected although none perished [Reference MacDonald19, Reference Creed and Scot-Skirving20].

At the turn of the century, central Italy became the focus of similar epidemics, with clusters appearing successively in Parma (1904–1905) [Reference Bertino21], Portoferraio on the island of Elba (1906) [Reference Queirolo22], Piombino (1908) [23], Porto San Giorgio (1909) [Reference Mancini24] and Soriano nel Cimino (1910) [Reference Cova25]. Simultaneous to the Portoferraio outbreak was an island-wide epidemic which afflicted an estimated 700 inhabitants with jaundice [Reference Queirolo22]. In 1916, another outbreak broke out in the mainland, this time in Galeata [Reference Pignataro26]. At all sites, fatalities were exclusive to pregnant women. Subsequently, except for one notification of a small cluster among natives in Bombay [Reference Tucker27], the flow of publications relating to these mysterious epidemics abated, until about the onset of the Second World War. Passing allusions had been made to jaundice epidemics in Russia prominent for deaths in pregnant women – there was one outbreak that hit Sverdlovsk between 1920 and 1921 [Reference Rabl28, Reference Zhumatov and Dardik29], and another in Tomsk (year of onset unspecified) [Reference Zhumatov and Dardik29] – but count data were not provided. Figure 1 summarizes the epidemics so far described that reported case-frequency data, mortality-frequency data, or both.

Fig. 1. Morbidity and mortality frequencies in hepatitis E-like epidemics of jaundice or viral hepatitis with pregnancy deaths, 1794–1946. Numerals at end of and alongside bars specify counts. C, Community-based; H, hospital-based. Roman numerals next to names of epidemic location denote class of epidemic according to likelihood of hepatitis E. I, Class I (plausible); II, class II (possible); III, class III (probable). Reference citations: Ludenscheid [Reference Kerksig8]; Roubaix [Reference Carpentier9]; St Pierre [Reference Saint-Vel1]; Limoges [Reference Bardinet10]; Paris [Reference Decaudin3, Reference Vinay7, Reference Hervieux11, Reference Decaisne12]; St Paul [Reference Smith16]; Heusenstamm [Reference Klingelhoeffer15]; Brisbane [Reference Hardie18]; Tennessee [Reference Young17]; Parma [Reference Bertino21]; Bombay [Reference Tucker27]; Portoferraio [Reference Queirolo22]; Piombino [23]; Porto San Giorgio [Reference Mancini24]; Soriano nel Cimino [Reference Cova25]; Galeata [Reference Pignataro26]; Hamet [Reference Yenikomshian and Dennis95]; Istanbul [Reference Kent96, Reference Liepmann97]; Tel Aviv [Reference Soferman101] and Jerusalem [Reference Zondek and Bromberg102].

Nosological and aetiological clarifications

Acute yellow atrophy was initially thought to be a specific disease entity [Reference McDonald30]. Over the early decades of the 20th century it was revealed instead as an outcome of insults to the liver by a variety of infectious agents as well as toxic chemicals, notably phosphorus, chloroform, cinchophen and trinitrotoluene [Reference Willcox31]. Close microscopic studies showed that regardless of cause, degenerative and necrotic changes could in a given hepatic lobule involve hepatocytes surrounding the central vein or the zone between it and the portal vein, or extend to include both zones, even the entire lobule [Reference Opie32] and these changes were variably accompanied by fatty metamorphosis, inflammatory infiltration, stromal collapse, phagocytosis, bile-ductular and hepatocytic regeneration, vascularization and haemorrhage, and fibrosis [Reference Cullinan33]. The form of yellow atrophy that was particularly severe in pregnant women was classified as idiopathic [Reference McDonald30, Reference Cullinan33].

Persuasive evidence implicating idiopathic yellow atrophy as representing the fatal stage of viral hepatitis came to light during the Second World War [Reference Lucké34Reference Havens and Anderson36] from necropsies performed in American soldiers and their contacts who perished after the soldiers contracted post-vaccinal hepatitis (they had been inoculated with attenuated yellow-fever virus which was cultured and stabilized in contaminated human serum) [Reference Havens and Anderson36]. Acute yellow atrophy, now recognized as having ‘no specific connotation but merely means any acute massive necrosis of the liver’ [Reference Mallory37], was replaced by a more functional, syndromic label that is still current: fulminant hepatic failure (FHF).

The term ‘hepatitis’ presumes inflammatory injury to hepatocytes and implicates the hepatic parenchyma, not mesenchyma, as the primary site of disease. Opposing this concept was ‘catarrhal jaundice’, thought to arise from plugging of the common bile duct by mucus produced from gastroduodenitis. Such notion came to dominate thinking regarding the pathogenesis of simple jaundice (that seemingly distinct form of acute jaundice that was generally self-resolving, not associated with cholelithiasis, and could occur epidemically or sporadically) [Reference Klemperer, Killian and Heyd38, Reference Findlay, MacCallum and Murgatroyd39]. It expanded to accommodate oedematous swelling of the ampulla of Vater and ascending cholangitis as contributing to jaundice. Against this mechanistic interpretation of pathogenesis were findings from prototypic dye-excretion tests and biochemical measurements in blood which pointed to hepatocytic injury [Reference Shattuck, Browne and Preston40]. More critically, whereas autopsy audits showed little or no extra-hepatic bile-duct obstruction [Reference Rich41], microscopic studies using autopsied livers from fatal cases of catarrhal jaundice and cases who happened to die of other causes [Reference Findlay and Dunlop42] and using aspirational liver biopsies conducted on living patients diagnosed with catarrhal jaundice [Reference Axenfeld and Brass43, Reference Dible, McMichael and Sherlock44] presented unequivocal evidence of degenerative pleomorphism among hepatocytes and disruption of the hepatic-cord architecture. Hepatonecrosis was accompanied by lobular, often periportal, infiltration of lymphocytes and other mononuclear cells. Catarrhal jaundice was, without doubt, a hepatitis.

Nor was catarrhal jaundice benign. When it broke out in families [Reference Findlay and Dunlop42, Reference Cockayne45] and among troops [Reference Eppinger46], fatalities could be observed in some cases although most recovered without sequelae. Such disparate outcomes elicited suspicion that acute yellow atrophy and catarrhal jaundice represented extreme ends of a spectrum. Morphological studies verified that the pathology of incipient liver atrophy was not significantly different from that of catarrhal jaundice [Reference Axenfeld and Brass43Reference Eppinger46], thereby unifying nosologically these two apparently disparate entities.

If the hepatic parenchyma were to be the seat of disease, the causative agent would be one that targets hepatocytes haematogenously from the general circulatory system, or more directly from the portal system. After a spirochaete was discovered as the cause of Weil's disease, extensive investigations were launched to determine if leptospires [Reference Levett47] could be the agent of epidemic catarrhal jaundice: they could not [Reference Findlay, MacCallum and Murgatroyd39]. The typhoid and paratyphoid bacilli were also implicated; any association between infection by these or other enteric bacteria and acute jaundice was later ascribed to intestinal infections and hepatitis co-prevailing under unsanitary conditions [Reference Havens and Wenner48].

During the Second World War the catastrophic epidemics of post-vaccinal hepatitis entangled with outbreaks of camp jaundice that were rife among Allied and Axis forces [Reference Lucké34Reference Havens and Anderson36, Reference Stokes and Miller49]. These debilitating epidemics galvanized efforts to identify the icterogenic agent. Two forms of hepatitis were confirmed, one form with a short and the other with a long incubation period. The former corresponded with what was being observed in the field as ‘infectious hepatitis’, essentially a filth disease, and the latter with ‘homologous serum hepatitis’, coined to embrace a variety of injection-transmitted diseases other than post-vaccinal jaundice such as post-arsphenamine (salvarsan) jaundice, transfusion jaundice and syringe jaundice [Reference Findlay, MacCallum and Murgatroyd39, Reference Mortimer50]. Significantly, jaundice was transmissible in human serial passage after the volunteers were inoculated with filtered material extracted from serum or stools (for infectious hepatitis), or from predominantly serum (for serum hepatitis), further implicating the icterogenic agent as a virus [Reference McDonald30, Reference Findlay, MacCallum and Murgatroyd39, Reference MacCallum51].

By the time catarrhal jaundice was abandoned from medical parlance [Reference Roy52], it had undergone major appellative transitions. ‘Catarrhal’ was replaced by terms that reflected with increasing precision the mode of disease acquisition or the aetiology; such terms (other than ‘infectious’) were: ‘infective’, ‘common infective’, ‘non-spirochaetal’, ‘epidemic’, and finally ‘virus’ or ‘viral’. The two last-mentioned terms were presumptive, since no viruses had yet been identified. As for ‘jaundice’, it was replaced with ‘hepatitis’, acknowledging that anicteric forms of the disease exist [Reference Sherman and Eichenwald53]. Although infectious hepatitis connoted the short-incubation form that was associated with faecal–oral (or enteric) transmission and recognized in waterborne outbreaks [Reference Mosley54], it could refer generically to both short- and long-incubation forms [Reference Krugman, Giles and Hammond55]. Whether the causative agent comprised strains of one organism or separate organisms [Reference Havens and Anderson36, Reference MacCallum51] was resolved after intensive serological studies and then electron microscopy characterized the agent of the short-incubation disease and that of the long-incubation disease to be distinct viruses, now known as hepatitis A virus (HAV) and hepatitis B virus (HBV), respectively. More years intervened before two other parenterally transmitted viruses, hepatitis C virus (HCV) and hepatitis D virus (HDV), and one other enterically transmitted virus, hepatitis E virus (HEV), were identified [Reference Gust and Feinstone56Reference Khuroo60].

Attribution of epidemics to hepatitis E

All the outbreaks so far described are more likely than not due to hepatitis E. The defining characteristic of a hepatitis E epidemic is its undue lethality for pregnant women, especially those who have entered the later stages of gestation [Reference Teo61]. Although all the five known agents of viral hepatitis can induce FHF in the infected host, observational studies have shown that in pregnant women, hepatitis A – whether occurring sporadically [Reference Farber62Reference Ryu65] or epidemically [Reference Ye66, Reference Willner67] – gives rise to no or very low mortality rates, and that deaths from FHF following acute hepatitis B either are absent or occur at significantly marginal rates compared to hepatitis E [Reference Acharya63, Reference Aziz68, Reference Jaiswal69]. As for hepatitis C and D, no tendency for pregnant women to develop FHF after their acquisition has yet been reported [Reference Gonzalez70]. Similarly, non-viral hepatitides that can expand into epidemics of jaundice, such as yellow fever [Reference Monath and Barrett71], leptospirosis [Reference Levett47] and louse-borne relapsing fever [Reference Bryceson72] do not share that predilection. Nor do other diseases for which jaundice could present although less prominently, e.g. typhoid, typhus, dengue and malaria [Reference Syhavong73]. Hepatitis E is therefore pre-eminent among infectious diseases in predisposing pregnant women to FHF [Reference Teo61].

Hepatotoxins, too, can potentially result in community-wide outbreaks of jaundice and liver failure [Reference Meggs74] but none was wont to bring about morbidities in pregnant women. A possible exception is tetracycline which in the 1960s tended to be administered intravenously in large doses to pregnant women with pyelonephritis, a practice that led to reports of excess deaths from liver failure [Reference Combes, Whalley and Adams75]. This antibiotic did not exist when the jaundice epidemics so far described occurred.

A second characteristic of hepatitis E is that during community outbreaks, clinical attack rates are highest among adolescents and young adults than children and older adults [Reference Teo76]. By contrast, when hepatitis A strikes a community, peak clinical attack rates tend to be among young children [Reference Gust and Feinstone56, Reference Jameel77]. A distinction between the two enterically transmitted viral hepatitides may therefore be made. That can be blurred, however, if a jaundice outbreak is associated with HAV and HEV co-transmission [Reference Jameel77Reference Lay85] or if a hepatitis E outbreak occurs in a locality where HAV infection is highly endemic [Reference Tandon86Reference Hasan, Omer and Al-Dulami88]. Furthermore, peak attack rates of hepatitis A can shift from children to young adults, but that shift is a relatively recent phenomenon [Reference Tapia-Conyer89, Reference Mathur and Arora90]. Still, other jaundice epidemics have been encountered which although primarily striking adults are associated with neither HAV transmission nor severe disease in pregnant women [Reference Birtaseviæ91Reference Arankalle94]; they may be caused by yet undiscovered icterogenic agents.

These limitations notwithstanding, a consideration of whether the distinguishing characteristics of hepatitis E, i.e. high attack rates in young adults and deaths in pregnant women, are revealed in historical documentations of jaundice epidemics permits any outbreak to be classified – along a gradation of certainty that the reports pertain to hepatitis E – as belonging to one three classes: class I (plausible), class II (possible), and class III (probable) (Table 1). Each of the epidemics represented in Figures 1–3 has been assigned a class following this classification scheme.

Table 1. Classification of hepatitis E-like epidemics

Epidemic escalations

After an apparent lull between the two world wars, reports of jaundice epidemics that were peculiarly lethal to pregnant women resurfaced. A change in trend to these outbreaks is perceptible: they were being reported more frequently; the venues were shifting eastward and southward; and their scale grew. All the outbreaks are readily assignable to class II or class III. Heralding this new era was a small cluster in 1935 in Hemet, Lebanon, which led to two fatalities, both in pregnant women [Reference Yenikomshian and Dennis95]. A year later and over a period of 16 months, all but one of 14 jaundiced pregnant women who were admitted with coma to the university hospital in Istanbul, Turkey, died (Fig. 1) [Reference Kent96]. Attending obstetricians were, like their European predecessors, mystified by the exclusivity of deaths among pregnant women. As Liepmann (1938) recounted:

But the strangest thing to our epidemic is, that in a time of widespread jaundice throughout the city and in all hospitals in Istanbul, only the pregnant women were affected by acute yellow atrophy, and non-pregnant women and men did not suffer it [Reference Liepmann97].

In Palestine, 1941, the first of a succession of hepatitis epidemics erupted, coinciding with the onset of mass immigration into the region. It broke out in detention camps and involved mainly young adults [Reference Kligler, Btesh and Koch98]. Pregnant women were noted to bear the brunt of severe hepatic disease and of deaths from acute yellow atrophy [Reference Leffkovitz99, Reference Btesh100] but count data were not reported. More indicative of hepatitis E was an outbreak that followed which generated steep increases in the number of jaundiced pregnant women admitted to hospitals in Tel-Aviv between 1942 and 1944, and in Jerusalem between 1944 and 1946, with case-fatality rates (CFRs) of 14% and 19%, respectively [Reference Soferman101, Reference Zondek and Bromberg102] (Fig. 1). Upsurges in immigration after the founding of Israel brought about even more dramatic rises in the frequency and extent of hepatitis epidemics [Reference Davies and Suchowolski103]. A notable outbreak that smouldered in the north in the 1950s led to excess hospital admissions of jaundiced pregnant women in Haifa, the CFR being about 9% [Reference Peretz, Paldi and Barzilai104] (Fig. 2). Predating it was a series from neighbouring Jezreel and Afula involving 55 cases observed sporadically over 10 years of which nine cases were fatal [Reference Asher105]. Notifications in Israel of such sporadic and outbreak occurrences subsequently ceased [Reference Shalev and Bassan106].

Fig. 2. Morbidity and mortality frequencies in hepatitis E-like epidemics of jaundice or viral hepatitis with pregnancy deaths, 1949–1976. Reference citations: Agra [Reference Wahi and Arora150]; Tunis [Reference Corcos108]; Algiers [Reference Bourdon and Ezes109]; Haifa [Reference Peretz, Paldi and Barzilai104]; Kazakhstan [Reference Zhumatov and Dardik29]; Delhi [Reference Viswanathan151]; Gwalior [Reference Phatak and Patil155]; Pointe-Noire [Reference Combescot de Marsaguet and Thomas133]; Rabat [Reference Bablet131]; Mecca [Reference Hammouda262]; Aurungabad [Reference Dhamdhere and Nadkarni156]; Prizren [Reference Perisić145]; Mitrovica [Reference Colaković, Dragović and Vućelić146]; NW Bosnia [Reference Kallai, Gaon and Pinjo147]; Bihac [Reference Birtasević148]; Gauhati [Reference Das157]; Tripoli, 1968–1970 [Reference Wyatt112]; Kathmandu Valley [Reference Hillis, Shrestha and Saha159]; Pietermaritzburg [Reference Parkes144]; Tripoli, 1975 [Reference Christie113] and Ahmedabad [Reference Sreenivasan158].

Along the southern Mediterranean littoral arose a succession of reports of fatal jaundice in pregnant women: first from Tunisia (from 1945) [Reference Corcos107, Reference Corcos108] thereafter Algeria (from 1952) [Reference Bourdon and Ezes109, Reference Houel, Fabregoule, Gares and Bourdon110] and then Morocco (from 1958) [Reference Hugonot111] (Fig. 1). Somewhat later, in 1968 and 1970, similar reports came from Libya [Reference Wyatt112, Reference Christie113]. In all these, jaundice in the wider community was also noted, but deaths in males and non-pregnant women were seldom observed. Features common to the illness suffered by pregnant women were: previous paucity of occurrences as perceived by the reporting physicians; onset during the third trimester; susceptibility of both native and expatriate women; fulminant course leading up to encephalopathy; high rates of fetal loss; and pathological findings redolent of classic acute yellow atrophy. Light microscopy of post-mortem or biopsy liver samples revealed frank hepatocytic necrosis, which was distinct from appearances associated with gestational conditions affecting the liver that could occasionally be fatal such as hyperemesis gravidarum, eclampsia and acute fatty liver of pregnancy [Reference Sheehan114]. These various features are consistent with hepatitis E being newly introduced to the region. By the end of the second decade following the Second World War, endemicity was firmly established: subsequent reports would relate to sporadic disease mainly [Reference Delons115Reference Ghazli121], whereas those related to outbreaks became occasional [Reference Gebreel and Dane118, Reference Belabbes122, Reference Benjelloun123].

The aforementioned class II or III epidemics struck the Maghreb [Reference Corcos107Reference Christie113] when epidemics of jaundice were breaking out among soldiers [Reference Merveille and Heuls124, Reference Petchot-Bacque125], mostly deployed from French Equatorial Africa [Reference Lemaire and Deroo126]. As the magnitude of the outbreaks and the extent of fulminant disease and cirrhosis among the military cases varied [Reference Merveille and Heuls124, Reference Petchot-Bacque125, Reference Gaubert127] and because no women were involved, it is not possible to assess the contribution of hepatitis E. Confounding that difficulty was the encroaching endemicity of parenterally transmitted hepatitis in the African continent, associated with mass vaccinations, widespread availability of syringe-mediated treatment for diseases such as yaws, syphilis and schistosomiasis, and of myriad other injection-based therapies including blood transfusions and plasma infusions administered to civilian and military populations [Reference Findlay, Kirk and Lewis128Reference Frank130]. The natural histories of the new forms of viral hepatitis were often grave [Reference Findlay, Kirk and Lewis128, Reference Bablet131] which contrasted with the essentially benign nature of epidemic catarrhal jaundice (insofar as it could be distinguished from leptospirosis, yellow fever and relapsing fever) that had episodically been reported from Africa since the First World War [Reference Beheyt129, Reference Kirk132]. Whether the higher morbidity and mortality rates were linked to dissemination of new and more virulent strains of HBV or HCV, or to HDV super- or co-infection of people with persistent HBV infection remains uncertain [Reference Mortimer50]. Nonetheless, a class II hepatitis E-like epidemic in 1958 was reported from Belgian Congo [Reference Combescot de Marsaguet and Thomas133], probably a massive one as >700 cases of jaundice were hospitalized (Fig. 1).

The striking observations reported from northern Africa prompted retrospective observational studies in Dakar, Senegal [Reference Mazaud, Moissincac and Labegorre134, Reference Payet135]. A major investigation of >400 jaundiced patients admitted to a single hospital between 1954 and 1959 found a CFR from acute hepatic failure of 24% in pregnant women, contrasting with 11% in non-pregnant women [Reference Payet135]. These findings are suggestive of hepatitis E, but in an endemic setting, as no community epidemics of jaundice were being reported. The situation is mirrored in Accra, Ghana, where over a 1-year period in 1963, and in the absence of a concurrent epidemic, hospitalized cases of presumptive viral hepatitis were studied; the clinical attack rate and the incidence rate of coma were both four times higher in pregnant than non-pregnant women [Reference Morrow136]. From Nigeria was reported a 1960 epidemic of jaundice that particularly afflicted pregnant women [Reference Morrow136, Reference Ogunlesi137] but further information is unavailable. Near-contemporaneous, autopsy-based audits conducted in Ibadan revealed massive hepatic necrosis to be a significant cause of maternal mortality, accounting for 20% of non-obstetric deaths in a 1957–1960 series [Reference Lawson138] and 8% of all deaths in a 1961–1968 series [Reference Ojo, Francis and Onifade139].

Reports of epidemics during the immediate decades after the Second World War in eastern and southern Africa did not mention deaths in pregnant women [Reference Beheyt129, Reference Kirk132, Reference Sood, Hulley and Hutt140] nor did those of studies into sporadic viral hepatitis [Reference Jindani, Bagshawe and Forrester141, Reference Moffat and Gelfand142]. An audit of viral hepatitis in pregnancy observed between 1957 and 1967 in a Johannesburg hospital uncovered only 12 cases, none fatal [Reference Hurwitz143]. Then, from 1974 to 1975, a steep rise was observed in the number of jaundiced women admitted to the obstetric wards in Pietermaritzburg [Reference Parkes144]. The CFR was 44%, and all the deaths followed hepatic coma (Fig. 2). Admissions of jaundiced patients to the medical wards showed a corresponding rise, pointing to a class III epidemic in the environs.

Meanwhile, a spate of class II and III epidemics befell several republics and provinces of what was then Yugoslavia. Occurring in the early 1960s and centered on Prizren (in Serbia) [Reference Perisić145], Mitrovica (in Kosovo) [Reference Colaković, Dragović and Vućelić146], an unidentified town in Bosnia [Reference Kallai, Gaon and Pinjo147], and Bihac (also in Bosnia) [Reference Birtasević148], they generated hospital-based CFRs in pregnant women that were unusually high, ranging from 28% to 43% (Fig. 2). Cases and deaths were almost exclusive to the poorer, Muslim communities. Representing the last of their kind in Europe, these epidemics appeared during a period when numerous waterborne outbreaks of jaundice erupted across the federation [Reference Birtasević149].

Elsewhere, other jaundice epidemics associated with pregnancy deaths were being reported. In the Indian subcontinent there was a 1949 cluster of in-patient cases outstanding for its 65% CFR among pregnant women [Reference Wahi and Arora150] (Fig. 2). It arose from an epidemic, whose magnitude is unknown, which affected villages around Agra. Six years later, a much larger outbreak hit Delhi: within 8 weeks, >250 people were dead, with almost half of them pregnant [Reference Viswanathan151] (Fig. 2). Of 1200 pregnant women notified as cases, the obstetric history of 339 was known, and of these, 101 delivered stillbirths or infants who died as neonates [Reference Naidu and Viswanathan152]. Before the Agra and Delhi outbreaks, jaundice epidemics were already being reported; nevertheless, none except the 1906 cluster (27) (Fig. 1) was recorded to have particularly killed pregnant women [Reference Roy52, Reference Raman153, Reference Patel154]. After the Delhi outbreak, more reports of class III epidemics ensued. Most affected relatively smaller conurbations [Reference Phatak and Patil155Reference Sreenivasan158] but in 1973, an epidemic swept over the Kathmandu valley in Nepal [Reference Hillis, Shrestha and Saha159] (Fig. 2). Shrestha & Maila, who had to face up to en masse hospital admissions that resulted, wrote a moving account of toiling pregnant women being felled by hepatitis E gone rampant:

Twenty-six were brought in coma. They gave history of jaundice of short duration of 2 to 7 days, but were still working till they suddenly became drowsy and comatose and brought to hospital. Of these, 3 were not aware of the disease and were still working the field till they were suddenly struck by hepatic encephalopathy [Reference Shrestha and Maila160].

The abrupt onset of FHF and its fatal outcome likely attenuate the accuracy by which CFRs relating to hepatitis E in pregnant women are calculated. Those who perish without having been admitted to the hospital or otherwise become notified would not have been counted. Also influencing the derivation of the CFR numerator is how the gestational status of the deceased is ascertained: whereas cases who are visibly pregnant would be identified, those in early pregnancy might not. The epidemic scale and intensity bear on both the numerator and denominator. Larger epidemics tend to mandate sample field-surveys, the morbidity and mortality data collected being then used to estimate the CFR [Reference Viswanathan151, Reference Dhamdhere and Nadkarni156, Reference Sreenivasan158, Reference Khuroo161166]. Such crude estimations would be unnecessary for small outbreaks since cases and deaths could be counted more closely or notified more directly. Finally, CFRs with denominators based on morbidity of community cases are probably lower than those based on morbidity of hospital inpatients as the latter would tend to capture the severer cases. To aid comparative assessments of CFRs, morbidity and mortality counts in Figures 1–4 are denoted according to whether they originated from the hospital (H) or the community (C).

Widening epidemic contexts

Retrospective serological testing for HAV and HBV in patients who developed jaundice during waterborne epidemics in India [Reference Wong167] revealed that they contracted what came to be known as enterically transmitted non-A, non-B (ET-NANB) hepatitis [Reference Reyes, Bradley and Lovett58]. ET-NANB hepatitis was, in turn, determined by later serological testing for anti-HEV antibodies to be mostly hepatitis E [Reference Arankalle94, Reference Khuroo168Reference Prakash170]. The Indian subcontinent has continued to host many epidemics of ET-NANB hepatitis and hepatitis E. Outbreaks have erupted across India, Nepal, Burma, Pakistan and Bangladesh, in both urban [Reference Jameel77, Reference Myint78, Reference Sailaja84, Reference Tandon86, Reference Das157, Reference Sreenivasan158, Reference Sreenivasan162, Reference Naik164, 166, Reference Khuroo171Reference Rab176] and rural [Reference Deo and Autkar174, 177Reference Dilawari180] settings (Figs 2–4). HEV strains associated with these outbreaks, whenever characterized, belonged to genotype 1, there being altogether four genotypes (1–4) that infect humans [Reference Arankalle181]. A very severe epidemic affected about 200 villages in the Kashmir valley in 1978 and 1979. It led to an estimated 600 deaths, two-thirds in pregnant women [Reference Khuroo161, Reference Khuroo168, Reference Khuroo171]. Some cases manifested a cholestatic form of disease similar to that in pregnant women with FHF in Dakar, Delhi and Accra [Reference Payet135, Reference Gupta and Smetana182, Reference Morrow183]. A larger epidemic visited the city of Kanpur during 1992 [Reference Naik164]. The CFR for pregnant women there (27%) was reportedly less than in Kashmir (73%), a disparity ascribable to mortality data for Kanpur having been based on hospital-inpatient counts and those for Kashmir projected from data obtained during a sample survey [Reference Khuroo161, Reference Khuroo171]. Nonetheless, the possibility is raised that outbreaks were caused by HEV strains of varying virulence. Indeed, a few confirmed hepatitis E outbreaks have been documented for which deaths when inquired into were absent [Reference Bhagyalaxmi, Gadhvi and Bhavsar184] or not found among pregnant women [Reference Bali185Reference Swain188].

Outbreaks apart, numerous case-series have been published [Reference Acharya63, Reference Aziz68, Reference Jaiswal69, Reference Bhasker Rao and Ganapathy189Reference Hossain215] as well as autopsy reviews [Reference Deodhar216] and audits [Reference Konar217, Reference Shrestha, Saha and Karki218] linking viral hepatitis, ET-NANB hepatitis and hepatitis E with pronounced maternal mortality rates. Fetal complications have also been frequent [Reference Khuroo and Kamili206, Reference Kumar207, Reference Bista and Rana209Reference Patra211, Reference Hossain215]. More recent, verbally reported autopsy data from population-based studies in Bangladesh reveal 20% of all maternal deaths and 10% of all neonatal deaths to be associated with jaundice in pregnant women, HEV being the chief suspect [Reference Gurley219]. Collectively, these reports indicate that for the last half century, hepatitis E in south Asia – whether epidemic or sporadic – has imposed enormous morbidity and mortality burdens on pregnant women and their infants in excess of that on the general population [Reference Clark220, Reference Labrique221].

Reports from Central Asia of epidemic hepatitis, also called Botkin's disease [Reference Tarejev222] were common in the immediate decades after the Second World War. Many waterborne epidemics were likely hepatitis A in view of the high clinical attack rates in children [Reference Tarejev222Reference Diachenko225]. Association with fatal FHF in pregnant women was specifically documented for two outbreaks: one outbreak (magnitude unknown) struck an agricultural area in southern Kazakhstan during the 1950s and elicited a CFR in hospitalized pregnant women of 10% [Reference Zhumatov and Dardik29] (Fig. 1); the other was in Kirgizstan between 1956 and 1957 with a CFR of 16% [Reference Farber62]. Over this period, CFRs reported for pregnant women with sporadic Botkin's disease in Central Asia (about 4%) [Reference Farber62, Reference Zakirov226] were similar to those in Russia (between 1% and 6%) [Reference Farber62, 227–Reference Romanov231]. Towards the end of the 1980s a succession of class III ET-NANB hepatitis epidemics struck Central Asia. These hit: Tashauz province, Turkmenistan (1984, and then 1985) [Reference Favorov232Reference Albetkova234]; southern Uzbekistan (1986) [Reference Favorov79, Reference Sharapov235]; the city of Leninabad, Tajikistan (1986) [Reference Rafiev83, Reference Iarasheva236]; eastern Uzbekistan (1987) [Reference Sharapov235]; and Inner Tien Shan, Kirgizstan (1987) [Reference Usmanov93] (Fig. 3). Typically autumnal in onset, lasting until winter and each affecting between 10 000 and 30 000 people [Reference Favorov237], they were particularly lethal to pregnant women, the CFRs (as estimated from sample surveys) ranging from 7% to 27%. Later testing of sera sampled from the cases confirmed that all the epidemics were hepatitis E [Reference Usmanov93, Reference Albetkova234, Reference Sharapov235, Reference Favorov237] and caused by HEV genotype 1 [Reference Favorov237]. Thereafter, except for a few scattered outbreaks [Reference Rafiev83, Reference Temper, Moroz and Chernysheva227], large-scale epidemics abated. To date, sporadic hepatitis E continues to be observed [Reference Rafiev83, Reference Sharapov235, Reference Iarasheva238].

Fig. 3. Morbidity and mortality frequencies in epidemics of hepatitis E-like, ET-NANB hepatitis with pregnancy deaths, 1978–1990. Kashmir Valley [Reference Khuroo161, Reference Khuroo168, Reference Khuroo171]; Azamgarh [Reference Tandon86]; Calcutta [Reference Pain, Chakraborty and Choudhury172]; Vidisha [Reference Chakraborty163]; Medea [Reference Belabbes122]; Kolhapur [Reference Sreenivasan162]; Rangoon [Reference Myint78]; Kathmandu Valley [Reference Kane178]; Tortiya [Reference Sarthou280]; Rundu [Reference Isaäcson278]; Tashauz [Reference Favorov232Reference Albetkova234]; S Uzbekistan [Reference Myint78, Reference Sharapov235]; Maun [Reference Mast, Kishioka, Suzuki, Mishiro and Oda285]; refugee camps, Somalia [284]; refugee camps, Sudan [284]; Karachi [Reference Smego and Khaliq173]; S. Xinjiang [Reference Cao239]; Sulangong [Reference Ji241] and Buldana [Reference Deo and Autkar174].

Attendant to the Tien Shan outbreak [Reference Usmanov93] were two consecutive class III ET-NANB epidemics that blighted neighbouring Xinjiang, China, in the autumns of 1987 and 1988. Together, they afflicted nearly 120 000 people (mostly Uighurs) in 23 counties and towns across three prefectures [Reference Cao239], yielding a CFR for pregnant women of 13% (Fig. 3). These occurrences also were later confirmed to be hepatitis E and caused by HEV genotype 1 [Reference Huang240]. Similar, but lesser-intensity outbreaks had earlier [Reference Ji241] and since [Reference Xia242] struck Xinjiang. In the rest of China and in Mongolia, prior ET-NANB hepatitis outbreaks had been described [Reference Zhuang, Wen, Xu and Melnick243] although details are unavailable. Even earlier documentations from China revealed extensive jaundice epidemics in the 1920s but pregnant women were not noted to be especially ill [Reference Wyatt244, Reference Robinson245]. A jaundice-in-pregnancy series from Taiwan covering cases observed from 1961 to 1974 found a 14% CFR associated with viral hepatitis [Reference Soong246]. An investigation in 1962 of Botkin's disease in pregnant women based in Ulan Bator reported a strikingly high CFR of 81% [Reference Gamma247]; whether this was generated in the course of an outbreak is unclear. Serologically confirmed HEV infection is now infrequent in Mongolia [Reference Tsatsralt-Od248]. In China, however, sporadic HEV infection and FHF still occur in pregnant women [Reference Zhu249Reference Li251]. A shift in HEV endemicity from genotype 1 to genotype 4 (and to a lesser extent, to genotype 3) is being observed [Reference Zhang252] so a decline in the rates of sporadic hepatitis E-related FHF in pregnant women may follow; genotypes 3 and 4, unlike genotype 1, are not closely associated with FHF in younger adults [Reference Teo61].

Four ET-NANB hepatitis or hepatitis E outbreaks have so far been reported from Southeast Asia: two which hit successively one district in West Kalimantan, Indonesia (1987 and 1991) [Reference Lubis253, 254]; one in southwestern Vietnam (1994) [Reference Corwin255]; and most recently one in Java, Indonesia (1998) [Reference Sedyaningsih-Mamahit256]. All the epidemic sites were riverine villages. Death rates were pronounced among pregnant women in the Kalimantan epidemics, the CFR calculated from the 1991 outbreak being 26% (Fig. 4). They were not encountered in the Vietnamese and Javan outbreaks, although surveillance for post-jaundice outcomes in pregnant women was in place. For the rest of Southeast Asia and in East Asia, sporadic hepatitis E is being reported but not severe disease in pregnant women [Reference Syhavong73, Reference Corwin257Reference Yano261]. In Japan, hepatitis E-associated FHF has been observed; peculiarly, it afflicts predominantly older people, reflecting the endemicity of HEV genotypes 3 and 4 rather than genotype 1 [Reference Teo76].

Fig. 4. Morbidity and mortality frequencies in serologically-confirmed hepatitis E epidemics with pregnancy deaths, 1987–2010. Kathmandu Valley [Reference Shrestha179]; Jammu [Reference Khuroo168]; Kamal [Reference Dilawari180]; Lower Shibeli region [Reference Bile277]; Sintang [Reference Lubis253]; Liboi [Reference Mast, Kishioka, Suzuki, Mishiro and Oda285]; Kanpur [Reference Naik164]; Djibouti [Reference Coursaget81]; Islamabad [Reference Rab176]; Bangui [Reference Goumba, Konamna and Komas282]; Darfur [Reference Boccia165]; Madi Opei and Palonga [Reference Teshale286]; Tongi [166] and Rajshahi [177].

In Mecca during 1958–1960, upsurges in admissions for jaundice to hospitals pointed to an ongoing class II outbreak but it was relatively benign (Fig. 2) [Reference Hammouda262]. Case-series studies of sporadic viral hepatitis conducted in other regions in the Middle East revealed variable rates of FHF and ensuing mortality in pregnant women [Reference Borhanmanesh263Reference Medhat266]. Given the lack of specific diagnostic testing, it cannot be excluded that such variation in rates reflects regional differences in endemicity of the hepatitis viruses. A more recent, prospective study of HEV infection in the United Arab Emirates found that 21% of women screened antenatally to be viraemic developed FHF as pregnancy progressed [Reference Kumar267] specifically associating HEV with detrimental maternal outcomes.

Reports of localized ET-NANB hepatitis epidemics from Mexico [Reference Velázquez87] (caused by HEV genotype 2 [Reference Huang268]) and similar-scale but more frequent hepatitis E outbreaks from Cuba [Reference Lay85, Reference Montalvo Villalba269] (caused by genotype 1) have not noted fatalities in pregnant women. Earlier reports of sporadic viral hepatitis in pregnant women from Brazil [Reference Shiroma270] and Mexico [Reference Reyes, Saldana García and Valenzuela271, Reference Díaz Saldaña272] showed deaths from hepatic failure, but without specific diagnostic testing attribution to hepatitis E is tenuous. Although sporadic hepatitis E has since been identified in Central and South America [Reference Lay85, Reference Lyra273Reference Ibarra275], there is little evidence to link it with severe maternal illness [Reference Reyes276].

Africa has continued to provide settings from which class III ET-NANB hepatitis and hepatitis E epidemics frequently break out. The largest outbreak lasted from 1988 to 1989 and affected >140 villages along the Shebeli River in Somalia [Reference Bile277]. Mortalities in the general and pregnant populations – however incompletely determined given the widespread and protracted nature of the epidemic – were appreciable (Fig. 4). Other outbreaks reported are clustered around urban centers: Medea, Algeria (1980–1981) [Reference Belabbes122]; Rundu, Namibia (1983 [Reference Isaäcson278] and then 1995 [Reference Maila, Bowyer and Swanepoel279]); Tortiya, Côte d'Ivoire (1982–1984) [Reference Sarthou280]; Maun, Botswana (1985) [Reference Byskov281]; Djibouti (1993) [Reference Coursaget81] and Bangui, Central African Republic (2002) [Reference Goumba, Konamna and Komas282]. Although relatively circumscribed and brief, FHF-associated fatalities in pregnant women were noted (Figs 3 and 4). For the 1995 Namibian outbreak no pregnant women died although FHF was observed [Reference Maila, Bowyer and Swanepoel279]. The transmitting HEV was identified as genotype 2 [Reference He283] contrasting with genotype 1 that was associated with the earlier outbreak [Reference Isaäcson278]. Refugee camps have been another, more recent epidemic setting. Outbreaks have occurred among displaced people held in camps situated in Somalia [284], Kenya [Reference Mast, Kishioka, Suzuki, Mishiro and Oda285], Sudan [Reference Boccia165, 284] and Uganda [Reference Teshale286]. Owing to the dense concentration of people being accommodated, the outbreaks were larger than those in the cities and towns [Reference Coursaget81, Reference Belabbes122, Reference Isaäcson278Reference Goumba, Konamna and Komas282]; correspondingly, death counts in pregnant women were higher (Figs 3 and 4). HEV infection remains endemic across much of Africa, as exemplified by findings from the many seroincidence studies conducted [Reference Belabbes122, Reference Rioche287Reference Adjei293]. Sporadic transmissions still pose fatal risk to pregnant women [Reference Belabbes122, Reference Mirghani, Saeed and Basama294Reference Hannachi299].

Implications

The narrative as assembled here dates back to the closing years of the 18th century, and traces the shift of sites of epidemic jaundice from Western Europe, the Caribbean, USA and Australia to Eastern Europe, Central and South Asia, and Africa. Accompanying that widening geographical reach is an increasing frequency and magnitude of the outbreaks. This pattern of dispersal could plausibly be an artifact of Western colonization, as outbreaks were reported by Western observers inquiring into diseases first at home, then in the colonies as territories were being possessed [Reference Guerra300, Reference Chernin301], and thereafter – during the post-colonial period – reported by native observers. Whether from expatriate or indigenous reporting, the paucity of pregnancy deaths in documentations of jaundice epidemics from South Asia and Africa during the pre-Second World War 20th century [Reference Roy52, Reference Beheyt129, Reference Bablet131, Reference Kirk132, Reference Raman153, Reference Patel154] is striking. Nonetheless, the possibility that there were outbreaks that went unnoticed or unrecorded cannot be excluded. Gaps in the narrative may also be due to limitations in the reach of this literature review, and missing or inaccessible records [Reference Rabl28, Reference Zhumatov and Dardik29, Reference Myint78, Reference Ogunlesi137, Reference Zhuang, Wen, Xu and Melnick243].

Other than an artifact of reporting, the epidemic history of hepatitis E here constructed and the pattern of diffusion inferred could reflect the manner by which the virulence of HEV for humans has changed over the last two centuries. All serologically confirmed hepatitis E outbreaks associated with pregnancy deaths (Fig. 4) are caused by HEV strains belonging to genotype 1, not the other genotypes. The class I, II and III and the ET-NANB hepatitis epidemics (Figs 1–3) may be presumed to be caused by HEV genotype 1 too. The time of appearance of the pre-20th century class I and II epidemics (Fig. 1) coincides with the time when HEV genotype 1 emerged from its putative immediate ancestor about 100–200 years ago, as estimated by recent molecular-clock analyses [Reference Purdy and Khudyakov302]. Moreover, the dramatic increase in the frequency and scale of post-Second World War class II and III, ET-NANB hepatitis and hepatitis E epidemics (Figs 1–4) corresponds to a period when there was a burst of genetic diversity in genotype 1 strains. How these strains lead to severe hepatic disease in the pregnant remains unknown [Reference Teo61]. Although studies of HEV-infected pregnant women in India have found higher levels of oestrogen, progesterone and β-human choriogonadotrophin in the blood [Reference Jilani303] and higher DNA-binding activity of NF-κB in peripheral blood mononuclear cells and liver [Reference Prusty304] of patients with FHF compared to those without FHF, the manner by which host factors interact with HEV in influencing the pathogenesis of FHF requires clarification.

The narrative also is one of tragedy in maternal and child health continuing into modern times, particularly for South Asia and Africa. To avert that tragedy requires universalizing access to drinking water and basic sanitation [305], in itself an arduous undertaking [Reference Hutton and Bartram306]. Necessarily complementing efforts to meet this challenge is the implementation of measures that are directed specifically to protect against or mitigate the pernicious outcome of HEV infection in pregnant women. Providing these women with antiviral prophylaxis during an epidemic is not yet an option.

Vaccination is a more pre-emptive and now an achievable means to prophylaxis. Two vaccines have completed clinical and safety efficacy trials [Reference Zhu249, Reference Shrestha307]. Whereas the development of one vaccine [Reference Shrestha307] has stopped [Reference Basnyat308], the production of the other vaccine [Reference Zhu249] is progressing and market approval is being sought. Sufficient quantities could soon be available to immunize communities where epidemics have arisen and HEV genotype 1 is endemic. It would then be possible to determine its efficacy against HEV infection and FHF in vaccinees who are or subsequently become pregnant, along with adverse obstetric and fetal outcomes that may ensue.

ACKNOWLEDGEMENTS

The author thanks: Z. E. Dimitrova for generation of the figures; T. Al-Hadithi, R. Aggarwal, M. Favorov, J. A. Frean, E. S. Gurley, Y. J. Hutin, S. Kamili, M. Khuroo, R. Larasati, E. E. Mast, P. P. Mortimer, M. A. Purdy, T. Rachmawati, R. Swanepoel, N. S. Xia and H. Zhuang for helpful discussions; J. Drobeniuc, L. M. Ganova-Raeva, Y. Khudyakov, A. P. Kourtis, L. Ruggiero, E. C. J. Teo, N. Usmanova, G. Vaughan and G. Xia for assistance with translation; and staff from the Public Health Library and Information of the Centers for Disease Control and Prevention (CDC), Biblioteca Polo San Paolo, Biblioteca Unificata Area Medica ‘Adolfo Ferrata’, the Resource Center of the American College of Obstetricians and Gynecologists, the Library of the Royal College of Obstetrics and Gynaecologists, and the Wellcome Library for facilitating access to documents. The findings and opinions in this review are the author's and do not represent the official position of the CDC.

DECLARATION OF INTEREST

None.

References

REFERENCES

1.Saint-Vel, O. Note on a form of severe jaundice in pregnant women [in French]. Gazette des Hôpitaux Civils et Militaires 1862; 65: 538539.Google Scholar
2.Ballot, . Jaundice epidemic observed in 1858 in Martinique in the Principality of St. Pierre [in French]. Gazette des Hôpitaux Civils et Militaires 1859; 62: 262.Google Scholar
3.Decaudin, E. Concomitance des maladies du foie et des reins, et en particulier des reins dans l'ictère. Paris, France: V. A. DeLahaye, 1877, pp. 117.Google Scholar
4.Hervieux, E. Puerperal jaundice [in French]. Gazette Médicale de Paris 1867; 22: 240245.Google Scholar
5.Ozanam, AF. Histoire médicale générale et particulière des maladies épidémiques, contagieuses et épizotiques qui ont régné en Europe depuis les temps les plus reculés, et notamment depuis le XIVe siècle jusqu'à nos jours, vol. 1. Paris: Méquignon-Marvis, 1817, pp. 320.Google Scholar
6.Wickham Legg, J. On the Bile, Jaundice, and Bilious Diseases. London: H. K. Lewis, 1880, pp. 719.Google Scholar
7.Vinay, C. Traité des maladies de la grossesse et des suites de couches. Paris, France: J. B. Baillière, 1894, pp. 836.Google Scholar
8.Kerksig, F. Of a jaundice epidemic [in German]. Journal der Practischen Arzneykunde und Wundarzneykunst 1799; 8: 94–109.Google Scholar
9.Carpentier, . Danger of jaundice in pregnant women [in French]. Revue Médico-chirurgicale de Paris 1854; 15: 268270.Google Scholar
10.Bardinet, . Of epidemic jaundice in pregnant women. Its influence as cause of abortion and mortality [in French]. L'Union Médicale 1863; 133: 242246.Google Scholar
11.Hervieux, E. Jaundice epidemic at La Maternité [in French]. Bulletin et Memoires de la Société Médicale des Hopitaux de Paris 1871; 8: 95–100.Google Scholar
12.Decaisne, . An epidemic of simple jaundice observed in Paris and in the vicinity [in French]. Gazette Hebdomadaire de Médecine et de Chirurgie 1872; 19: 44.Google Scholar
13.Ollivier, A. Study of puerperal chronic diseases [in French]. Archives de Médecine Générale 1873; 1: 567589.Google Scholar
14.Fuchs, RG. Poor and Pregnant in Paris: Strategies for Survival in the Nineteenth Century. Piscataway, New Jersey: Rutgers University Press, 1992, pp. 326.CrossRefGoogle Scholar
15.Klingelhoeffer, . Contribution to epidemic jaundice [in German]. Berliner Klinische Wochenschrift 1876; 6: 7677.Google Scholar
16.Smith, CE. A synopsis of ten cases of jaundice occurring in pregnant women. Northwestern Medical and Surgical Journal 1874, June, pp. 436440.Google Scholar
17.Young, WB. Simple and malignant jaundice of pregnancy: report of three cases. Medical News 1898; 78: 618621.Google Scholar
18.Hardie, D. Acute atrophy of the liver in pregnancy. Australasian Medical Gazette 1890; 9: 179184.Google Scholar
19.MacDonald, TF. A new epidemic. Australasian Medical Gazette 1887; 7: 247248.Google Scholar
20.Creed, JM, Scot-Skirving, R. On two cases of acute atrophy of the liver (?) in which recovery took place. Australasian Medical Gazette 1889; 8: 259260.Google Scholar
21.Bertino, A. Of acute liver atrophy in pregnancy [in Italian]. La Ginecologia 1908; 14: 417448.Google Scholar
22.Queirolo, GB. Epidemic jaundice [in Italian]. La Riforma Medica 1907; 23: 930934.Google Scholar
23.Anon.Epidemic of severe jaundice in pregnant women in Piombino [in Italian]. La Ginecologia Moderna 1908; 1: 649652.Google Scholar
24.Mancini, F. Epidemic of jaundice [in Italian]. Il Policlinico Sezione Pratica 1910; 17: 1113.Google Scholar
25.Cova, E. On an epidemic of jaundice in Soriano nel Cimino, and the relationship of the disease with pregnancy [in Italian]. Folia Gynaecologia 1911; 5: 331425.Google Scholar
26.Pignataro, L. An epidemic of jaundice [in Italian]. Il Policlinico Sezione Pratica 1917; 24: 287288.Google Scholar
27.Tucker, EFG. An epidemic of malignant jaundice in Bombay. Indian Medical Gazette 1907; 13: 47.Google Scholar
28.Rabl, R. Geographical-pathological investigations of jaundice, acute yellow atrophy, liver cirrhosis and cholelithiasis [in German]. Archiv für Schiffs und Tropen-Hygiene 1934; 38 (Suppl.): S1–80.Google Scholar
29.Zhumatov, KhZh, Dardik, FG. Epidemic hepatitis in pregnancy [in Russian]. Akusherstvo i Ginekologiia 1958; 34: 2632.Google Scholar
30.McDonald, S. Acute yellow atrophy in syphilis (a preliminary note). British Medical Journal 1918; 1: 7678.CrossRefGoogle ScholarPubMed
31.Willcox, W. Toxic jaundice. Lancet 1931; 218: 111117.CrossRefGoogle Scholar
32.Opie, EL. On the relation of combined intoxication and bacterial infection to necrosis of the liver, acute yellow atrophy and cirrhosis. Journal of Experimental Medicine 1910; 12: 367387.CrossRefGoogle ScholarPubMed
33.Cullinan, ER. Idiopathic jaundice (often recurrent) associated with subacute necrosis of the liver. St Bartholomew's Hospital Reports 1936; 19: 55–142.Google Scholar
34.Lucké, B. The pathology of fatal epidemic hepatitis. American Journal of Pathology 1944; 20: 471593.Google ScholarPubMed
35.Lucké, B, Mallory, T. The fulminant form of epidemic hepatitis. American Journal of Pathology 1946; 22: 867945.Google ScholarPubMed
36.Havens, WP. Viral hepatitis. In: Anderson, RS, ed. Internal Medicine in World War II, vol. III. Washington, DC: Office of the Surgeon General, Department of the Army, 1969, pp. 331384.Google Scholar
37.Mallory, TB. The pathology of epidemic hepatitis. Journal of the American Medical Association 1947; 134: 655662.CrossRefGoogle ScholarPubMed
38.Klemperer, P, Killian, JA, Heyd, CG. The pathology of icterus catarrhalis. Archives of Pathology 1926; 2: 631652.Google Scholar
39.Findlay, GM, MacCallum, FO, Murgatroyd, F. Observations bearing on the aetiology of infective hepatitis (so-called epidemic catarrhal jaundice). Transactions of the Royal Society of Tropical Medicine and Hygiene 1939; 32: 575586.CrossRefGoogle Scholar
40.Shattuck, HF, Browne, JC, Preston, M. Clinical value for some recent tests for liver function. American Journal of Medical Sciences 1925; 170; 510518.CrossRefGoogle Scholar
41.Rich, AR. The pathogenesis of the forms of jaundice. Bulletin of the Johns Hopkins Hospital 1930; 47: 338377.Google Scholar
42.Findlay, GM, Dunlop, JL. A fatal case of acute necrosis of the liver associated with epidemic catarrhal jaundice. British Medical Journal 1932; 1: 652656.CrossRefGoogle ScholarPubMed
43.Axenfeld, H, Brass, K. Biopsy and clinical investigations of the so-called icterus catarrhalis [in German]. Frankfurter Zeitschrift für Pathologie 1942; 57: 147236.Google Scholar
44.Dible, JH, McMichael, J, Sherlock, SPV. Pathology of acute hepatitis. Lancet 1943; 2: 402408.CrossRefGoogle Scholar
45.Cockayne, EA. Catarrhal jaundice, sporadic and epidemic, and its relation to acute yellow atrophy of the liver. Quarterly Journal of Medicine 1912; 6: 129.Google Scholar
46.Eppinger, H. The pathogenesis of jaundice [in German]. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1922; 34: 1539.Google Scholar
47.Levett, PN. Leptospirosis. Clinical Microbiological Reviews 2001; 14: 296326.CrossRefGoogle ScholarPubMed
48.Havens, WP, Wenner, HA. Infectious hepatitis complicated by secondary invasion with salmonella. Journal of Clinical Investigations 1946; 25: 4552.CrossRefGoogle ScholarPubMed
49.Stokes, JF, Miller, AA. An outbreak of severe infective hepatitis in Burma. Quarterly Journal of Medicine 1947; 16: 211236.Google ScholarPubMed
50.Mortimer, PP. Arsphenamine jaundice and the recognition of instrument-borne virus infection. Genitourinary Medicine 1995; 71: 109119.Google ScholarPubMed
51.MacCallum, FO. The natural history of long-incubation period hepatitis. Journal of Clinical Pathology 1972; 6 (Suppl.): S28–33.CrossRefGoogle ScholarPubMed
52.Roy, H. Sporadic infective hepatitis in Calcutta. Calcutta Medical Journal 1946; 43: 303309.Google ScholarPubMed
53.Sherman, IL, Eichenwald, HF. Viral hepatitis: descriptive epidemiology based on morbidity and mortality statistics. Annals of Internal Medicine 1956; 44: 10491069.CrossRefGoogle ScholarPubMed
54.Mosley, JW. Water-borne infectious hepatitis. New England Journal of Medicine 1959; 261: 703708; 748753.CrossRefGoogle ScholarPubMed
55.Krugman, S, Giles, JP, Hammond, J. Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection. Journal of the American Medical Association 1967; 200: 365373.CrossRefGoogle ScholarPubMed
56.Gust, ID, Feinstone, SM. Hepatitis A. Boca Raton, Florida: CRC Press, 1988, pp. 239.Google Scholar
57.Blumberg, BS. Hepatitis B: the Hunt for a Killer Virus. Princeton, New Jersey: Princeton University Press, 2002, pp. 242.CrossRefGoogle Scholar
58.Reyes, GR, Bradley, DW, Lovett, M. New strategies for isolation of low abundance viral and host cDNAs: application to cloning of the hepatitis E virus and analysis of tissue-specific transcription. Seminars in Liver Disease 1992; 12: 289300.CrossRefGoogle ScholarPubMed
59.Purcell, RH. The discovery of the hepatitis viruses. Gastroenterology 1993; 104: 955963.CrossRefGoogle ScholarPubMed
60.Khuroo, MS. Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane. Virus Res 2011; 161: 3–14.CrossRefGoogle ScholarPubMed
61.Teo, CG. Subduing the hepatitis E python. Epidemiology and Infection 2009; 137: 480484.CrossRefGoogle ScholarPubMed
62.Farber, NA. Viral hepatitis in pregnant women – the relationship of the severity of the disease to the etiology of the infection [in Russan]. Terapevticheskiĭ Arkhiv 1990; 62: 8–10.Google Scholar
63.Acharya, SK, et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology 1996; 23: 14481455.CrossRefGoogle Scholar
64.Elinav, E, et al. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology 2006; 130: 11291134.CrossRefGoogle ScholarPubMed
65.Ryu, HS, et al. Clinical characteristics and gestational complications associated with acute hepatitis A in pregnancy [in Korean]. Korean Journal of Gastroenterology 2010; 56: 307313.CrossRefGoogle ScholarPubMed
66.Ye, JY. Outcome of pregnancy complicated by hepatitis A in the urban districts of Shanghai [in Chinese]. Chinese Journal of Obstetetrics and Gynecology 1990; 25: 219221, 252.Google ScholarPubMed
67.Willner, IR, et al. Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States. Annals of Internal Medicine 1998; 128: 111114.CrossRefGoogle ScholarPubMed
68.Aziz, AB, et al. Prevalence and severity of viral hepatitis in Pakistani pregnant women: a five year hospital based study. Journal of the Pakistan Medical Association 1997; 47: 198201.Google ScholarPubMed
69.Jaiswal, SP, et al. Viral hepatitis during pregnancy. Indian Journal of Gynaecology and Obstetrics 2001; 72: 103108.Google ScholarPubMed
70.Gonzalez, F, et al. Acute hepatitis C during the third trimester of pregnancy [in French]. Gastroentérologie Clinique et Biologique 2006; 30: 786789.CrossRefGoogle ScholarPubMed
71.Monath, TP, Barrett, AD. Pathogenesis and pathophysiology of yellow fever. Advances in Virus Research 2003; 60: 343395.CrossRefGoogle ScholarPubMed
72.Bryceson, AD, et al. Louse-borne relapsing fever. Quarterly Journal of Medicine 1970; 39: 129170.Google ScholarPubMed
73.Syhavong, B, et al. The infective causes of hepatitis and jaundice amongst hospitalised patients in Vientiane, Laos. Transactions of the Royal Society of Tropical Medicine and Hygiene 2010; 104: 475483.CrossRefGoogle ScholarPubMed
74.Meggs, WJ. Epidemics of mold poisoning past and present. Toxicology and Industrial Health 2009; 25: 571576.CrossRefGoogle ScholarPubMed
75.Combes, B, Whalley, PJ, Adams, RH. Tetracycline and the liver. Progress in Liver Diseases 1972; 4: 589596.Google ScholarPubMed
76.Teo, CG. Much meat, much malady: changing perceptions of the epidemiology of hepatitis E. Clinical Microbiology and Infection 2010; 16: 2432.CrossRefGoogle ScholarPubMed
77.Jameel, S, et al. Enteric non-A, non-B hepatitis: epidemics, animal transmission, and hepatitis E virus detection by the polymerase chain reaction. Journal of Medical Virology 1992; 37: 263270.CrossRefGoogle ScholarPubMed
78.Myint, H, et al. A clinical and epidemiological study of an epidemic of non-A non-B hepatitis in Rangoon. American Journal of Tropical Medicine and Hygiene 1985; 34: 11831189.CrossRefGoogle Scholar
79.Favorov, MO, et al. Characteristics of viral hepatitis non-A, non-B with a fecal-oral mechanism of transmission of the infection in southern Uzbekistan [in Russian]. Voprosy Virusologii 1989; 34: 436442.Google ScholarPubMed
80.Vrati, S, Giri, DK, Parida, SK, Talwar, GP. An epidemic of non-A, non-B hepatitis in south Delhi: epidemiological studies and transmission of the disease to rhesus monkeys. Archives of Virology 1992; 125: 319326.CrossRefGoogle ScholarPubMed
81.Coursaget, P, et al. Outbreak of enterically-transmitted hepatitis due to hepatitis A and hepatitis E viruses. Journal of Hepatology 1998; 28: 745750.CrossRefGoogle ScholarPubMed
82.Kumar, S, et al. Virological investigation of a hepatitis E epidemic in North India. Singapore Medical Journal 2006; 47: 769773.Google ScholarPubMed
83.Rafiev, KhK. Virus hepatitis E: its specific epidemiological features in the Republic of Tajikistan [in Russian]. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii 1999; 3: 2629.Google Scholar
84.Sailaja, B, et al. Outbreak of waterborne hepatitis E in Hyderabad, India, 2005. Epidemiology and Infection 2009; 137: 234240.CrossRefGoogle ScholarPubMed
85.Lay, LAR, et al. Dual infection with hepatitis A and E viruses in outbreaks and in sporadic clinical cases: Cuba 1998–2003. Journal of Medical Virology 2008; 80: 798802.Google Scholar
86.Tandon, BN, et al. An epidemic of non-A non-B hepatitis in north India. Indian Journal of Medical Research 1982; 75: 739744.Google Scholar
87.Velázquez, O, et al. Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986–1987. Journal of the American Medical Association 1990; 263: 32813285.CrossRefGoogle ScholarPubMed
88.Hasan, ARS, Omer, AR, Al-Dulami, AA. Occurrence of an outbreak of acute hepatitis E infection in Baquba City. Iraqi Journal of Community Medicine 2006; 19: 2022.Google Scholar
89.Tapia-Conyer, R, et al. Hepatitis A in Latin America: a changing epidemiologic pattern. American Journal of Tropical Medicine and Hygiene 1999; 61: 825829.CrossRefGoogle ScholarPubMed
90.Mathur, P, Arora, NK. Epidemiological transition of hepatitis A in India: issues for vaccination in developing countries. Indian Journal of Medical Research 2008; 128: 699704.Google ScholarPubMed
91.Birtaseviæ, B, et al. Water-borne infectious hepatitis in Bosanski Petrovac during 1963–1964 [in Serbian]. Vojnosanitetski Pregled 1966; 23: 96–100.Google Scholar
92.Mitarnun, W. Fulminant hepatitis, possible virus origin: a report of seventeen cases in southern Thailand. Journal of the Medical Association of Thailand 1990; 73: 674683.Google ScholarPubMed
93.Usmanov, RK, et al. A comparative study of enteral hepatitis E (non-A, non-B) in the valley and mountainous areas of Kirghizia [in Russian]. Voprosy Virusologii 1991; 36: 6669.Google ScholarPubMed
94.Arankalle, VA, et al. Seroepidemiology of water-borne hepatitis in India and evidence for a third enterically-transmitted hepatitis agent. Proceedings of the National Academy of Sciences of USA 1994; 91: 34283432.CrossRefGoogle ScholarPubMed
95.Yenikomshian, H A, Dennis, EW. Outbreak of epidemic jaundice at Hemet, Lebanese Republic. Transactions of the Royal Society of Tropical Medicine and Hygiene 1938; 32: 189196.CrossRefGoogle Scholar
96.Kent, C. Observations of fourteen cases of acute yellow atrophy [in German]. Zentralblatt für Gynäkologie 1938; 62: 429437.Google Scholar
97.Liepmann, W. Endemic occurrence of acute yellow atrophy in the University Women's Clinic, Istanbul [in German]. Internationaal Congres voor Verloskunde en Gynaecologie: Amsterdam 4–8 May 1938. Vol. 2. Leiden, The Netherlands: Brill, 1938, pp. 262274.Google Scholar
98.Kligler, IJ, Btesh, DS, Koch, W. Observations on two epidemics of infective hepatitis in Palestine among recent immigrants. Journal of Infectious Diseases 1944; 74: 234246.Google Scholar
99.Leffkovitz, M. Infectious epidemic jaundice [in Hebrew]. Harefuah 1943; 25: 2428.Google Scholar
100.Btesh, S. Infective hepatitis in Palestine. Transactions of the Royal Society of Tropical Medicine and Hygiene 1944; 38: 3547.CrossRefGoogle Scholar
101.Soferman, N. Infectious epidemic jaundice and pregnancy [in Hebrew]. Harefuah 1945; 28: 217.Google Scholar
102.Zondek, B, Bromberg, YM. Infectious hepatitis in pregnancy. Journal of Mount Sinai Hospital New York 1947; 14: 222243.Google ScholarPubMed
103.Davies, AM, Suchowolski, A. The epidemiology in infectious hepatitis in Israel. Journal of Hygiene 1961; 59: 123132.CrossRefGoogle ScholarPubMed
104.Peretz, A, Paldi, A, Barzilai, D. Infectious hepatitis in pregnancy [in Hebrew]. Harefuah 1955; 48: 212215.Google ScholarPubMed
105.Asher, C. Infectious hepatitis in pregnancy [in Hebrew]. Dapim Refuiim 1953; 12: 284286.Google Scholar
106.Shalev, E, Bassan, HM. Viral hepatitis during pregnancy in Israel. International Journal of Gynaecology and Obstetrics 1982; 20: 7378.CrossRefGoogle ScholarPubMed
107.Corcos, A. Cases of primary jaundice in Tunisia [in French]. Bulletin de l'Académie Nationale de Medicine 1952; 136: 248253.Google ScholarPubMed
108.Corcos, A. Icterus gravis and pregnancy: 8 cases [in French]. La Presse Médicale 1954; 62: 544.Google ScholarPubMed
109.Bourdon, R, Ezes, H. Infectious hepatitis during pregnancy; critical synthesis of 36 observations made from 1952 to 1956 [in French]. Gynécologie et Obstétrique 1956; 55: 288311.Google ScholarPubMed
110.Houel, E, Fabregoule, M, Gares, R, Bourdon, R. Malignant forms of viral hepatitis during pregnancy [in French]. La Semaine des Hôpitaux de Paris 1958; 34: 10371043.Google ScholarPubMed
111.Hugonot, R, et al. Severe jaundice epidemic in Morocco [in French]. Maroc Médical 1961; 40: 948952.Google ScholarPubMed
112.Wyatt, GB. Pregnancy hepatitis in Libya. Lancet 1977; 1: 12041205.CrossRefGoogle ScholarPubMed
113.Christie, AB, et al. Pregnancy hepatitis in Libya. Lancet 1976; 2: 827829.CrossRefGoogle ScholarPubMed
114.Sheehan, HL. Jaundice in pregnancy. American Journal of Obstetrics and Gynecology 1961; 81: 427440.CrossRefGoogle Scholar
115.Delons, S, et al. Severe jaundice in pregnant women in Morocco [in French]. Revue Médico-chirurgicale des Maladies du Foie 1968; 43: 117130.Google ScholarPubMed
116.Rungs, H. Severe forms of viral hepatitis [in French]. Maroc Médical 1972; 52: 2734.Google ScholarPubMed
117.Kharouf, M, et al. Hepatitis and pregnancy in Tunis. 103 cases compared with 100 cases who were not pregnant [in French]. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 1980; 9: 887894.Google Scholar
118.Gebreel, AO, Dane, DS. Hepatitis in pregnancy in Libya. Annals of Tropical Medicine and Parasitology 1983; 77: 321322.CrossRefGoogle ScholarPubMed
119.Nouasria, B, et al. Fulminant viral hepatitis and pregnancy in Algeria and France. Annals of Tropical Medicine and Parasitology 1986; 80: 623629.CrossRefGoogle ScholarPubMed
120.Ben Hamed, S, et al. Jaundice and pregnancy. Apropos of 62 cases [in French]. Revue Française de Gynécologie et d'Obstétrique 1988; 83: 543545.Google ScholarPubMed
121.Ghazli, M, et al. Jaundice and pregnancy. The role of viral hepatitis [in French]. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 1993; 22: 529531.Google ScholarPubMed
122.Belabbes, EH, et al. Epidemic non-A, non-B viral hepatitis in Algeria: strong evidence for its spreading by water. Journal of Medical Virology 1985; 16: 257263.CrossRefGoogle ScholarPubMed
123.Benjelloun, S, et al. Seroepidemiological study of an acute hepatitis E outbreak in Morocco. Research in Virology 1997; 148: 279287.CrossRefGoogle ScholarPubMed
124.Merveille, P, Heuls, J. An epidemic of virus hepatitis in the colonial camps of Fréjus [in French]. Médecine Tropicale 1951; 11: 401426.Google ScholarPubMed
125.Petchot-Bacque, P. Epidemic viral hepatitis in 1955–1956 in the Constantine military district of troops in East Algeria; 3,239 cases [in French]. Revue du Corps de Santé Militaire 1957; 13: 378391.Google ScholarPubMed
126.Lemaire, S, Deroo, E. Histoire des Tirailleurs. Paris: Seuil Jeunesse, 2010, pp. 61.Google Scholar
127.Gaubert, C. The comatose forms of epidemic viral hepatitis. Apropos of 47 cases [in French]. Journal de Médecine de Bordeaux et du Sud-Ouest 1963; 140: 13071315.Google ScholarPubMed
128.Findlay, GM, Kirk, R, Lewis, DJ. Yellow fever and the Anglo-Egyptian Sudan: the differential diagnosis of yellow fever. Annals of Tropical Medicine and Parasitology 1941; 35: 140164.Google Scholar
129.Beheyt, P. Aetiology of the epidemics of jaundice in Central Africa. Tropical and Geographical Medicine 1958; 10: 1420.Google ScholarPubMed
130.Frank, C, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355: 887891.CrossRefGoogle ScholarPubMed
131.Bablet, J. Severe jaundice and the black African [in French]. Bulletin de la Société de Pathologie Exotique et de ses Filiales 1942; 35: 281313.Google Scholar
132.Kirk, R. Infective hepatitis in the Sudan. Journal of Tropical Medicine and Hygiene 1961; 64: 185190.Google ScholarPubMed
133.Combescot de Marsaguet, G, Thomas, J. On the subject of 5 cases of recovery from hepatic coma of viral origin in the course of pregnancy [in French]. Médecine Tropicale 1961; 21: 4558.Google ScholarPubMed
134.Mazaud, R, Moissincac, J, Labegorre, J. Icterigenic hepatitis of pregnancy [in French]. Médecine Tropicale 1959; 19: 7–22.Google ScholarPubMed
135.Payet, M, et al. Icterigenic hepatitis in pregnancy. Apropos of 200 cases in Africans [in French]. Bulletin de la Société de Pathologie Exotique et de ses Filiales 1961; 54: 398423.Google ScholarPubMed
136.Morrow, RH, et al. Epidemiology of viral hepatitis in Accra, Ghana. Transactions of the Royal Society of Tropical Medicine and Hygiene 1969; 63: 755767.CrossRefGoogle ScholarPubMed
137.Ogunlesi, TO. Hepatic failure in the tropics. British Medical Journal 1968; 2: 809812.CrossRefGoogle ScholarPubMed
138.Lawson, JB. Maternal mortality in West Africa. Ghana Medical Journal 1962; 1: 31–6.Google Scholar
139.Ojo, OA, Francis, TI, Onifade, A. Massive liver necrosis in pregnancy. West African Medical Journal 1971; 20: 339344.Google ScholarPubMed
140.Sood, U, Hulley, WSC, Hutt, MSR. Viral hepatitis in Karamoja. Makerere Medical Journal 1966; 10: 4649.Google Scholar
141.Jindani, A, Bagshawe, A, Forrester, AT. Viral hepatitis in Kenya. A preliminary report. East African Medical Journal 1970; 47: 138141.Google Scholar
142.Moffat, HJ, Gelfand, M. Viral hepatitis in Africans in Rhodesia. Central African Journal of Medicine 1974; 20: 245250.Google ScholarPubMed
143.Hurwitz, MB. Jaundice in pregnancy: a 10-year study and review. South African Medical Journal 1970; 44: 219222.Google Scholar
144.Parkes, JR. Fatal jaundice in pregnancy. South African Medical Journal 1978; 54: 406409.Google ScholarPubMed
145.Perisić, V, et al. Course and consequences of acute infectious hepatitis in pregnant women in the epidemic of Prizren and vicinity in year 1962–1963 [in Serbian]. Glas Srpska Akademija Nauka I Umetnosti Odeljenje Medicinskih Nauka 1969; 22: 7584.Google Scholar
146.Colaković, B, Dragović, D, Vućelić, M. Epidemiological and clinical interrelations between infectious hepatitis and pregnancy [in Serbian]. Medicinski Pregled 1972; 25: 181185.Google Scholar
147.Kallai, L, Gaon, J, Pinjo, F. Hepatitis and pregnancy [in German]. Wiener Zeitschrift für Innere Medizin und Ihre Grenzgebiete 1967; 48: 186195.Google Scholar
148.Birtasević, B, et al. Mass epidemic of infectious hepatitis in Cazinska Krajina [in Serbian]. Vojnosanitetski Pregled 1966; 23: 174183.Google ScholarPubMed
149.Birtasević, B, et al. Observations on water-borne epidemics of viral hepatitis in Yugoslavia [in Serbian]. Vojnosanitetski Pregled 1967; 24: 340343.Google ScholarPubMed
150.Wahi, PN, Arora, MM. Epidemic hepatitis. New England Journal of Medicine 1952; 248: 451454.CrossRefGoogle Scholar
151.Viswanathan, R. The Delhi outbreak of infectious hepatitis: epidemiology. Indian Journal of Medical Research 1957; 45 (Suppl.): S1–29.Google Scholar
152.Naidu, SS, Viswanathan, R. Infectious hepatitis in pregnancy during Delhi epidemic. Indian Journal of Medical Research 1957; 45 (Suppl.): S71–76.Google ScholarPubMed
153.Raman, TK. Infective hepatitis. Journal of the Indian Medical Association 1946; 15: 165180.Google ScholarPubMed
154.Patel, TB. An epidemic of infective hepatitis in Bijapur district (Bombay Province). Journal of the Indian Medical Association 1946; 15: 401402.Google ScholarPubMed
155.Phatak, LV, Patil, K. A study of infective hepatitis in pregnancy. Indian Journal of Medical Science 1956; 10: 594601.Google Scholar
156.Dhamdhere, MR, Nadkarni, MG. Infectious hepatitis at Aurangabad. Report of an outbreak. Indian Journal of Medical Science 1962; 16: 10061015.Google ScholarPubMed
157.Das, RK. Infective hepatitis in pregnancy. Journal of Obstetrics and Gynaecology of India 1968; 18: 903914.Google Scholar
158.Sreenivasan, MA, et al. Epidemiological investigations of an outbreak of infectious hepatitis in Ahmedabad city during 1975–76. Indian Journal of Medical Research 1978; 67: 197206.Google ScholarPubMed
159.Hillis, A, Shrestha, SM, Saha, NK. An epidemic of infectious hepatitis in the Kathmandu Valley. Journal of the Nepal Medical Association 1973; 11: 145149.Google Scholar
160.Shrestha, SM, Maila, DS. Viral A hepatitis in pregnancy during Kathmandu epidemic. Journal of the Nepal Medical Association 1975; 13: 5870.CrossRefGoogle Scholar
161.Khuroo, MS, et al. Incidence and severity of viral hepatitis in pregnancy. American Journal of Medicine 1981; 70: 252255.CrossRefGoogle ScholarPubMed
162.Sreenivasan, MA, et al. A sero-epidemiologic study of a water-borne epidemic of viral hepatitis in Kolhapur City, India. Journal of Hygiene 1984; 93: 113122.CrossRefGoogle ScholarPubMed
163.Chakraborty, S, et al. Observations on outbreaks of viral hepatitis in Vidisha and Rewa district of Madhya Pradesh, 1980. Journal of Communicable Diseases 1983; 15: 242–8.Google Scholar
164.Naik, SR, et al. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bulletin of the World Health Organization 1992; 70: 597604.Google ScholarPubMed
165.Boccia, D, et al. High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan. Clinical Infectious Diseases 2006; 42: 16791684.CrossRefGoogle ScholarPubMed
166.International Centre for Diarrhoeal Disease Research, Bangladesh.Outbreak of hepatitis E in a low income urban community in Bangladesh. Health Sciences Bulletin 2009; 7: 1420.Google Scholar
167.Wong, DC, et al. Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology. Lancet 1980; 8200: 876879.CrossRefGoogle Scholar
168.Khuroo, MS. Hepatitis E: the enterically transmitted non-A, non-B hepatitis. Indian Journal of Gastroenterology 1991; 10: 96–100.Google ScholarPubMed
169.Arankalle, VA, et al. Contribution of HEV and HCV in causing fulminant non-A, non-B hepatitis in western India. Journal of Viral Hepatitis 1995; 2: 189193.CrossRefGoogle ScholarPubMed
170.Prakash, C. Serological diagnosis of jaundice epidemics in India. Southeast Asian Journal of Tropical Medicine and Public Health 1998; 29: 497502.Google Scholar
171.Khuroo, MS. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. .American Journal of Medicine 1980; 68: 818824.CrossRefGoogle ScholarPubMed
172.Pain, GC, Chakraborty, AK, Choudhury, NR. Outbreak of non-A non-B type viral hepatitis in a Calcutta slum. Journal of the Indian Medical Association 1983; 80: 125128.Google Scholar
173.Smego, RA Jr., Khaliq, AA. Epidemic non-A non-B hepatitis in urban Karachi, Pakistan. American Journal of Tropical Medicine and Hygiene 1988; 38: 628632.CrossRefGoogle ScholarPubMed
174.Deo, PR, Autkar, MS. Epidemic of viral hepatitis in Buladana district, Maharashtra state. Indian Journal of Public Health 1991; 35: 8788.Google ScholarPubMed
175.Jameel, S, et al. Enteric non-A, non-B hepatitis: epidemics, animal transmission, and hepatitis E virus detection by the polymerase chain reaction. Journal of Medical Virology 1992; 37: 263270.CrossRefGoogle ScholarPubMed
176.Rab, MA, et al. Water-borne hepatitis E virus epidemic in Islamabad, Pakistan: a common source outbreak traced to the malfunction of a modern water treatment plant. American Journal of Tropical Medicine and Hygiene 1997; 57: 151157.CrossRefGoogle Scholar
177.International Centre for Diarrhoeal Disease Research, Bangladesh.Hepatitis E outbreak in Rajshahi City Corporation. Health Sciences Bulletin 2010; 8: 1218.Google Scholar
178.Kane, MA, et al. Epidemic non-A, non-B hepatitis in Nepal. Recovery of a possible etiologic agent and transmission studies in marmosets. Journal of the American Medical Association 1984; 252: 31403145.CrossRefGoogle ScholarPubMed
179.Shrestha, S, et al. An epidemic of hepatitis E in Nepal: clinical and epidemiological study. Journal of the Institute of Medicine 1990; 12: 195204.Google Scholar
180.Dilawari, JB, et al. Hepatitis E virus: epidemiological, clinical and serological studies of north Indian epidemic. Indian Journal of Gastroenterology 1994; 13: 4448.Google ScholarPubMed
181.Arankalle, VA, et al. Phylogenetic analysis of hepatitis E virus isolates from India (1976–1993). Journal of General Virology 1999; 80: 16911700.CrossRefGoogle ScholarPubMed
182.Gupta, DN, Smetana, HF. The histopathology of viral hepatitis as seen in the Delhi epidemic (1955–56). Indian Journal of Medical Research 1957; 45 (Suppl.): S101–113.Google ScholarPubMed
183.Morrow, RH Jr., et al. Unusual features of viral hepatitis in Accra, Ghana. Annals of Internal Medicine 1968; 68: 12501264.CrossRefGoogle ScholarPubMed
184.Bhagyalaxmi, A, Gadhvi, M, Bhavsar, BS. Epidemiological investigation of an outbreak of infectious hepatitis in Dakor Town. Indian Journal of Community Medicine 2007; 32: 277279.CrossRefGoogle Scholar
185.Bali, S, et al. Hepatitis E epidemic with bimodal peak in a town of north India. Indian Journal of Public Health 2008; 52: 189193, 199.Google Scholar
186.Chauhan, NT, et al. Epidemic investigation of the jaundice outbreak in Girdharnagar, Ahmedabad, Gujarat, India, 2008. Indian Journal of Community Medicine 2010; 35: 294297.CrossRefGoogle ScholarPubMed
187.Vivek, R, et al. Investigation of an epidemic of Hepatitis E in Nellore in south India. Tropical Medicine and International Health 2010; 15: 13331339.CrossRefGoogle ScholarPubMed
188.Swain, SK, et al. A hepatitis E outbreak caused by a temporary interruption in a municipal water treatment system, Baripada, Orissa, India, 2004. Transactions of the Royal Society of Tropical Medicine and Hygiene 2010; 104: 6669.CrossRefGoogle Scholar
189.Bhasker Rao, K, Ganapathy, MN. Infectious hepatitis complicating pregnancy. Journal of Obstetrics and Gynaecology of India 1956; 6: 210216.Google Scholar
190.Gupta, NP, et al. Infective hepatitis in Lucknow: a survey of 10 year hospital records. Journal of the Indian Medical Association 1958; 30: 107113.Google ScholarPubMed
191.Kamat, SA, Deshpande, RS. Infective hepatitis: a clinical study of 2,000 cases. Journal of the Association of Physicians India 1967; 15: 495497.Google Scholar
192.D'Cruz, IA, Balani, SG, Iyer, LS. Infectious hepatitis and pregnancy. Obstetrics and Gynecology 1968; 31: 449455.Google Scholar
193.Narayana Rao, AV, et al. Infectious hepatitis in pregnancy and puerperium – a study of 60 cases. Indian Journal of Medical Research 1969; 23: 471478.Google Scholar
194.Shah, CP, et al. The aetiological pattern of jaundice in Gujarat. Journal of the Indian Medical Association 1970; 55: 1114.Google ScholarPubMed
195.Bhalerao, VR, Desi, VP, Pai, DN. Viral hepatitis in pregnancy. Indian Journal of Public Health 1974; 18: 165170.Google ScholarPubMed
196.Trivedi, DR, et al. Fulminant hepatic failure. Journal of the Indian Medical Association 1974; 63: 122125.Google ScholarPubMed
197.Zuberi, SJ, Samad, F, Jafarey, SN. Pattern of jaundice in pregnancy. Journal of the Pakistan Medical Association 1979; 29: 3537.Google ScholarPubMed
198.Khuroo, MS, et al. Acute sporadic non-A, non-B hepatitis in India. American Journal of Epidemiology 1983; 118: 360364.CrossRefGoogle ScholarPubMed
199.Bal, V, et al. Virological markers and antibody responses in fulminant viral hepatitis. Journal of Medical Virology 1987; 23: 7582.CrossRefGoogle ScholarPubMed
200.Nayak, NC, et al. Aetiology and outcome of acute viral hepatitis in pregnancy. Journal of Gastroenterology and Hepatology 1989; 4: 345352.CrossRefGoogle ScholarPubMed
201.Raju, GS, et al. Fulminant viral hepatitis: Indian experience. Journal of Gastroenterology and Hepatology 1989; 4: 161165.CrossRefGoogle ScholarPubMed
202.Sarkar, CS, Giri, AK, Maity, TK. Jaundice in pregnancy: a clinical study. Journal of the Indian Medical Association 1990; 5: 117118.Google Scholar
203.Hamid, SS, et al. Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis? Journal of Hepatology 1996; 25: 2027.CrossRefGoogle ScholarPubMed
204.Jaiswal, SB, et al. Aetiology and prognostic factors in hepatic failure in central India. Tropical Gastroenterology 1996; 17: 217220.Google ScholarPubMed
205.Beniwal, M, et al. Prevalence and severity of viral hepatitis and fulminant hepatitis during pregnancy: a prospective study from north India. Indian Journal of Medical Microbiology 2003; 21: 184185.CrossRefGoogle ScholarPubMed
206.Khuroo, MS, Kamili, S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. Journal of Viral Hepatitis 2003; 10: 6169.CrossRefGoogle ScholarPubMed
207.Kumar, A, et al. Hepatitis E in pregnancy. International Journal of Gynaecology and Obstetrics 2004; 85: 240244.CrossRefGoogle ScholarPubMed
208.Dahiya, M, et al. Acute viral hepatitis in third trimester of pregnancy. Indian Journal of Gastroenterology 2005; 24: 128129.Google ScholarPubMed
209.Bista, BK, Rana, A. Acute hepatitis E in pregnancy – study of 16 cases. Journal of the Nepal Medical Association 2006; 45: 182185.Google Scholar
210.Rathi, U, Bapat, M, Rathi, P, Abraham, P. Effect of liver disease on maternal and fetal outcome – a prospective study. Indian Journal of Gastroenterology 2007; 26: 5963.Google ScholarPubMed
211.Patra, S, et al. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Annals of Internal Medicine 2007; 147: 2833.CrossRefGoogle ScholarPubMed
212.Bhatia, V, et al. A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse? Hepatology 2008; 48: 15771585.CrossRefGoogle ScholarPubMed
213.Devarbhavi, H, et al. Pregnancy-associated acute liver disease and acute viral hepatitis: differentiation, course and outcome. Journal of Hepatology 2008; 49: 930935.CrossRefGoogle ScholarPubMed
214.Al-Mahtab, M, et al. HEV infection as an aetiologic factor for acute hepatitis: experience from a tertiary hospital in Bangladesh. Journal of Health Population and Nutrition 2009; 27: 1419.CrossRefGoogle Scholar
215.Hossain, N, et al. Liver dysfunction in pregnancy: an important cause of maternal and perinatal morbidity and mortality in Pakistan. Obstetric Medicine 2009; 2: 1720.CrossRefGoogle ScholarPubMed
216.Deodhar, KP, et al. Viral hepatitis during pregnancy. (Autopsy study of 45 cases to evaluate the cause of death.). Journal of Postgraduate Medicine 1971; 17: 3742.Google ScholarPubMed
217.Konar, M, et al. Maternal mortality (ten years' survey in Eden Hospital). Journal of the Indian Medical Association 1980; 75: 4551.Google ScholarPubMed
218.Shrestha, NS, Saha, R, Karki, C. Near-miss maternal morbidity and maternal mortality at Kathmandu Medical College Teaching Hospital. Kathmandu University Medical Journal 2010; 8: 222226.CrossRefGoogle ScholarPubMed
219.Gurley, ES, et al. Estimating the burden of maternal and neonatal deaths associated with jaundice in Bangladesh: The possible role of hepatitis E infection. American Journal of Public Health (in press).Google Scholar
220.Clark, KL, et al. The socioeconomic impact of hepatitis E in Nepal. American Journal of Tropical Medicine and Hygiene 1999; 61: 505–10.CrossRefGoogle ScholarPubMed
221.Labrique, AB, et al. Epidemiology and risk factors of incident hepatitis E virus infections in rural Bangladesh. American Journal of Epidemiology 2010; 172: 952961.CrossRefGoogle ScholarPubMed
222.Tarejev, EM. Current aspects of the problem of epidemic hepatitis: Botkin's disease [in French]. Revue Médico-chirurgicale des Maladies du Foie 1960; 35: 225–46.Google ScholarPubMed
223.Zhumatov, KhZh, Dardik, FG. An outbreak of Botkin's disease caused by contaminated water [in Russian]. Voprosy Virusologii 1958; 3: 3943.Google ScholarPubMed
224.Dardik, FG. Some aspects of the epidemiology and prevention of Botkin's disease in the Tselina district [in Russian]. Zdravookhranenie Kazakhstana 1962; 22: 5860.Google Scholar
225.Diachenko, PN, et al. On the epidemiology of Botkin's disease (epidemic hepatitis) in Kirghizia [in Russian]. Sovetskoe Zdravookhranenie Kirgizii 1966; 3: 3741.Google ScholarPubMed
226.Zakirov, IZ. Epidemic hepatitis and its effect on pregnancy, fetus and newborn [in Russian]. Akusherstvo i Ginekologiia 1964; 40: 2428.Google ScholarPubMed
227.Temper, BA, Moroz, RI, Chernysheva, AV. Course of Botkin's disease in pregnancy [in Russian]. Klinicheskaia Meditsina 1959; 37: 6771.Google ScholarPubMed
228.Zhendrinskii, IP. Course of pregnancy in Botkin's disease [in Russian]. Akusherstvo i Ginekologiia 1963; 39: 2026.Google ScholarPubMed
229.Rychnev, VE. Course of pregnancy in Botkin's disease [in Russian]. Voprosy Okhrany Materinstva i Detstva 1964; 10: 56–9.Google Scholar
230.Elizarov, NN. Pregnancy, labor and puerperium in epidemic hepatitis (Botkin's disease) [in Russian]. Voprosy Okhrany Materinstva i Detstva 1965; 10: 6772.Google Scholar
231.Romanov, IuA. Clinico-epidemiologic parallells in Botkin's disease during pregnancy and the lactation period [in Russian]. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1968; 45: 109113.Google ScholarPubMed
232.Favorov, MO, et al. Clinico-epidemiological characteristics and diagnosis of viral non-A, non-B hepatitis with fecal and oral mechanisms of transmission of the infection [in Russian]. Voprosy Virusologii 1986; 31: 6569.Google ScholarPubMed
233.Shakhgildian, IV, et al. Epidemiological characteristics of non-A, non-B viral hepatitis with a fecal-oral transmission mechanism [in Russian]. Voprosy Virusologii 1986; 31: 175179.Google ScholarPubMed
234.Albetkova, A, et al. Characterization of hepatitis E virus from outbreak and sporadic cases in Turkmenistan. Journal of Medical Virology 2007; 79: 16961702.CrossRefGoogle ScholarPubMed
235.Sharapov, MB, et al. Acute viral hepatitis morbidity and mortality associated with hepatitis E virus infection: Uzbekistan surveillance data. BMC Infectious Diseases 2009; 9: 35.CrossRefGoogle ScholarPubMed
236.Iarasheva, DM, et al. The etiological structure of acute viral hepatitis in Tadzhikistan in a period of decreased morbidity [in Russian]. Voprosy Virusologii 1991; 36: 454456.Google Scholar
237.Favorov, MO, et al. Hepatitis E [in Russian]. Zhurnal Epidemiologii i Mikrobiologii 1996; 61: 9095.Google Scholar
238.Iarasheva, DM, et al. The epidemiological diagnosis of ‘fecal-oral’ hepatitis E in Tajikistan [in Russian]. Zhurnal Epidemiologii i Mikrobiologii 1993; 58: 6366.Google Scholar
239.Cao, XY, et al. Epidemiological and etiological studies on enterically transmitted non-A non-B hepatitis in the south part of Xinjiang [in Chinese]. Chinese Journal of Experimental and Clinical Virology 1989; 3: 110.Google Scholar
240.Huang, RT, et al. Isolation and identification of hepatitis E virus in Xinjiang, China. Journal of General Virology 1992; 73: 11431148.CrossRefGoogle ScholarPubMed
241.Ji, X. An outbreak of non A non B hepaitits in Xinjiang Province [in Chinese]. Chinese Journal of Preventive Medicine 1986; 5: 2729.Google Scholar
242.Xia, X. An epidemiologic survey on a type E hepatitis (HE) outbreak [in Chinese]. Chinese Journal of Epidemiology 1991; 12: 257260.Google ScholarPubMed
243.Zhuang, H. Hepatitis E and strategies for its control. In: Wen, YM, Xu, ZY, Melnick, JL, eds. Viral Hepatitis in China: Problems and Control Strategies. Monographs in Virology, vol. 19. Basel: Karger, 1992, pp. 126139.Google Scholar
244.Wyatt, HG. Attacks of jaundice in Shansi. China Medical Journal 1929; 43: 5253.Google Scholar
245.Robinson, HL. Some observations made during an outbreak of epidemic jaundice. China Medical Journal 1929; 43: 118121.Google Scholar
246.Soong, YK, et al. Jaundice during pregnancy: review of 47 cases. Journal of the Formosan Medical Association 1979; 78: 485494.Google ScholarPubMed
247.Gamma, V. Clinical aspects of toxic dystrophy of the liver in pregnant women with Botkin's disease (according to the data of the Infectious Disease Hospital of Ulan-Bator) [in Russian]. Sovetskaia Meditsina 1965; 28: 9395.Google Scholar
248.Tsatsralt-Od, B, et al. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia. Journal of Medical Virology 2006; 78: 542550.CrossRefGoogle Scholar
249.Zhu, FC, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376: 895902.CrossRefGoogle ScholarPubMed
250.Zhang, S, et al. Clinical characteristics and risk factors of sporadic hepatitis E in central China. Virology Journal 2011; 8: 152.CrossRefGoogle ScholarPubMed
251.Li, XM, et al. Clinical characteristics of fulminant hepatitis in pregnancy. World Journal of Gastroenterology 2005; 11: 46004603.CrossRefGoogle ScholarPubMed
252.Zhang, W, et al. Hepatitis E virus genotype diversity in eastern China. Emerging Infectious Diseases 2010; 16: 16301632.CrossRefGoogle ScholarPubMed
253.Lubis, I. Outbreak of hepatitis E in West Kalimantan [in Indonesian]. Cermin Dunia Kedokteran 1994; 95: 4346.Google Scholar
254.Anon.Results of the investigation of a hepatitis outbreak in the downstream sub-district of Kayan, Sintang, West Kalimantan [in Indonesian]. Berita Epidemiologi Republik Indonesia 1991; 3: 2142.Google Scholar
255.Corwin, AL, et al. A waterborne outbreak of hepatitis E virus transmission in southwestern Vietnam. American Journal of Tropical Medicine and Hygiene 1996; 54: 559562.CrossRefGoogle ScholarPubMed
256.Sedyaningsih-Mamahit, ER, et al. First documented outbreak of hepatitis E virus transmission in Java, Indonesia. Transactions of the Royal Society of Tropical Medicine and Hygiene 2002; 96: 398404.CrossRefGoogle ScholarPubMed
257.Corwin, AL, et al. Acute viral hepatitis in Hanoi, Viet Nam. Transactions of the Royal Society of Tropical Medicine and Hygiene 1996; 90: 647648.CrossRefGoogle ScholarPubMed
258.Saat, Z, et al. A four year review of acute viral hepatitis cases in the east coast of peninsular Malaysia (1994–1997). Southeast Asian Journal of Tropical Medicine and Public Health 1999; 30: 106109.Google ScholarPubMed
259.Lee, GK, et al. Trends in importation of communicable diseases into Singapore. Annals of the Academy of Medicine of Singapore 2010; 39: 764770.CrossRefGoogle ScholarPubMed
260.Kang, HM, et al. Recent etiology and clinical features of acute viral hepatitis in a single center of Korea [in Korean]. Korean Journal of Hepatology 2007; 13: 495502.CrossRefGoogle Scholar
261.Yano, K, et al. Japan National Hospital Acute Hepatitis Study Group. Dynamic epidemiology of acute viral hepatitis in Japan. Intervirology 2010; 53: 7075.CrossRefGoogle ScholarPubMed
262.Hammouda, AA. Acute virus hepatitis and pregnancy. Journal of Obstetrics and Gynaecology of the British Empire 1962; 69: 680682.CrossRefGoogle Scholar
263.Borhanmanesh, F, et al. Viral hepatitis during pregnancy. Severity and effect on gestation. Gastroenterology 1973; 64: 304312.CrossRefGoogle ScholarPubMed
264.Gelpi, AP. Viral hepatitis complicating pregnancy: mortality trends in Saudi Arabia. International Journal of Gynaecology and Obstetrics 1979; 17: 7377.CrossRefGoogle Scholar
265.Al-Kandari, S, et al. Viral hepatitis and pregnancy in Kuwait. Transactions of the Royal Society of Tropical Medicine and Hygiene 1987; 81: 395397.CrossRefGoogle ScholarPubMed
266.Medhat, A, et al. Acute viral hepatitis in pregnancy. International Journal of Gynaecology and Obstetrics 1993; 40: 2531.CrossRefGoogle ScholarPubMed
267.Kumar, RM, et al. Seroprevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. European Journal of Obstetrics Gynecology and Reproductive Biology 2001; 100: 9–15.CrossRefGoogle ScholarPubMed
268.Huang, CC, et al. Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV). Virology 1992; 191: 550558.CrossRefGoogle ScholarPubMed
269.Montalvo Villalba, MC, et al. Hepatitis E virus genotype 1, Cuba. Emerging Infectious Diseases 2008; 14: 13201322.CrossRefGoogle Scholar
270.Shiroma, M, et al. Viral hepatitis in pregnancy. Diagnosis, mortality and evolution of pregnancy [in Portuguese]. Revista do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 1969; 24: 349360.Google ScholarPubMed
271.Reyes, VE, Saldana García, R, Valenzuela, J. Hepatitis and pregnancy [in Spanish]. Ginecología y Obstetricia de México 1971; 30: 635653.Google Scholar
272.Díaz Saldaña, J, et al. Viral hepatitis during pregnancy [in Spanish]. Ginecología y Obstetricia de México 1978; 43: 399404.Google ScholarPubMed
273.Lyra, AC, et al. HEV, TTV and GBV-C/HGV markers in patients with acute viral hepatitis. Brazilian Journal of Medical and Biological Research 2005; 38: 767775.CrossRefGoogle ScholarPubMed
274.Schlauder, GG, et al. Identification of 2 novel isolates of hepatitis E virus in Argentina. Journal of Infectious Diseases 2000; 182: 294297.CrossRefGoogle ScholarPubMed
275.Ibarra, H, et al. Acute hepatitis caused by virus A, E and non A-E in Chilean adults [in Spanish]. Revista Médica de Chile 2001; 129: 523530.Google Scholar
276.Reyes, HB, et al. Acute fulminating hepatitis non-A non-B in pregnancy: a clinical case of probable sporadic hepatitis caused by E virus [in Spanish]. Revista Chilena de Obstetricia y Ginecología 1995; 60: 199204.Google Scholar
277.Bile, K, et al. Contrasting roles of rivers and wells as sources of drinking water on attack and fatality rates in a hepatitis E epidemic in Somalia. American Journal of Tropical Medicine and Hygiene 1994; 51: 466474.CrossRefGoogle Scholar
278.Isaäcson, M, et al. An outbreak of hepatitis E in Northern Namibia, 1983. American Journal of Tropical Medicine and Hygiene 2000; 62: 619625.CrossRefGoogle ScholarPubMed
279.Maila, HT, Bowyer, SM, Swanepoel, R. Identification of a new strain of hepatitis E virus from an outbreak in Namibia in 1995. Journal of General Virology 2004; 85: 8995.CrossRefGoogle ScholarPubMed
280.Sarthou, JL, et al. Characterization of an antigen-antibody system associated with epidemic non-A, non-B hepatitis in West Africa and experimental transmission of an infectious agent of primates. Annales de l'Institut Pasteur Virology 1986; 437E: 225232.CrossRefGoogle Scholar
281.Byskov, J, et al. An outbreak of suspected water-borne epidemic non-A non-B hepatitis in northern Botswana with a high prevalence of hepatitis B carriers and hepatitis delta markers among patients. Transactions of the Royal Society of Tropical Medicine and Hygiene 1989; 83: 110116.CrossRefGoogle ScholarPubMed
282.Goumba, AI, Konamna, X, Komas, NP. Clinical and epidemiological aspects of a hepatitis E outbreak in Bangui, Central African Republic. BMC Infectious Diseases 2011; 11: 93.CrossRefGoogle ScholarPubMed
283.He, J, et al. Molecular characterization of a hepatitis E virus isolate from Namibia. Journal of Biomedical Science 2000; 7: 334348.CrossRefGoogle ScholarPubMed
284.Centers for Disease Control and Prevention.Enterically transmitted non-A, non-B Hepatitis – East Africa. Morbidity and Mortality Weekly Report 1987; 36: 241244.Google Scholar
285.Mast, E, et al. Hepatitis E among refugees in Kenya: minimal apparent person-to-person transmission, evidence for age-dependent disease expression, and new serological assays. In: Kishioka, K, Suzuki, H, Mishiro, S, Oda, T, eds. Viral Hepatitis and Liver Disease. Tokyo: Springer-Verlag, 1994, pp. 375378.CrossRefGoogle Scholar
286.Teshale, EH, et al. Hepatitis E epidemic, Uganda. Emerging Infectious Diseases 2010; 16: 126129.CrossRefGoogle ScholarPubMed
287.Rioche, M, et al. High incidence of sporadic non-A, non-B hepatitis in Morocco: epidemiologic study [in French]. Bulletin de la Société de Pathologie Exotique 1991; 84: 117127.Google ScholarPubMed
288.Crato, M, et al. Viral markers of acute hepatitis: A, B, C, D, and E in Dakar. October 92–October 93 [in French]. Dakar Médical 1993; 38: 183185.Google Scholar
289.McCarthy, MC, et al. Acute hepatitis E infection during the 1988 floods in Khartoum, Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene 1994; 88: 177.CrossRefGoogle ScholarPubMed
290.Tucker, TJ, et al. Hepatitis E in South Africa: evidence for sporadic spread and increased seroprevalence in rural areas. Journal of Medical Virology 1996; 50: 117119.3.0.CO;2-D>CrossRefGoogle ScholarPubMed
291.Rioche, M, et al. Incidence of sporadic hepatitis E in Ivory Coast based on still problematic serology. Bulletin of the World Health Organization 1997; 75: 349354.Google ScholarPubMed
292.Coursaget, P, et al. Role of hepatitis E virus in sporadic cases of acute and fulminant hepatitis in an endemic area (Chad). American Journal of Tropical Medicine and Hygiene 1998; 58: 330334.CrossRefGoogle Scholar
293.Adjei, AA, et al. Unexpected elevated alanine aminotransferase, aspartate aminotransferase levels and hepatitis E virus infection among persons who work with pigs in accra, Ghana. Virology Journal 2010; 7: 336.CrossRefGoogle ScholarPubMed
294.Mirghani, OA, Saeed, OK, Basama, FM. Viral hepatitis in pregnancy. East African Medical Journal 1992; 69: 445449.Google ScholarPubMed
295.Tsega, E, et al. Hepatitis E virus infection in pregnancy in Ethiopia. Ethiopian Medical Journal 1993; 31: 173181.Google ScholarPubMed
296.Strand, RT, et al. Infectious aetiology of jaundice among pregnant women in Angola. Scandinavian Journal of Infectious Diseases 2003; 35: 401403.CrossRefGoogle ScholarPubMed
297.Ahmed, RE, Karsany, MS, Adam, I. Brief report: acute viral hepatitis and poor maternal and perinatal outcomes in pregnant Sudanese women. Journal of Medical Virology 2008; 80: 17471748.CrossRefGoogle ScholarPubMed
298.Adjei, AA, et al. Hepatitis E virus infection is highly prevalent among pregnant women in Accra, Ghana. Virology Journal 2009; 6: 108.CrossRefGoogle ScholarPubMed
299.Hannachi, N, et al. Seroprevalence and risk factors of hepatitis E among pregnant women in central Tunisia [in French]. Pathologie et Biologie 2011; 59: e115–118.CrossRefGoogle ScholarPubMed
300.Guerra, F. Medical colonization of the New World. Medical History 1963; 7: 147154.CrossRefGoogle ScholarPubMed
301.Chernin, E. The early British and American journals of tropical medicine and hygiene: an informal survey. Medical History 1992; 36: 7083.CrossRefGoogle ScholarPubMed
302.Purdy, MA, Khudyakov, YE. Evolutionary history and population dynamics of hepatitis E virus. PLoS One 2010; 5: e14376.CrossRefGoogle ScholarPubMed
303.Jilani, N, et al. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. Journal of Gastroenterology and Hepatology 2007; 22: 676–82.CrossRefGoogle ScholarPubMed
304.Prusty, BK, et al. Selective suppression of NF-ΚBp65 in hepatitis virus-infected pregnant women manifesting severe liver damage and high mortality. Molecular Medicine 2007; 13: 518526.CrossRefGoogle Scholar
305.World Health Organization and United Nations Children's Fund.Meeting the MDG Drinking Water and Sanitation Target: the Urban and Rural Challenge of the Decade. Geneva: World Health Organization Press, 2006, pp. 41.Google Scholar
306.Hutton, G, Bartram, J. Global costs of attaining the Millennium Development Goal for water supply and sanitation. Bulletin of the World Health Organization 2008; 86: 1319.CrossRefGoogle Scholar
307.Shrestha, MP, et al. Safety and efficacy of a recombinant hepatitis E vaccine. New England Journal of Medicine 2007; 356: 895903.CrossRefGoogle ScholarPubMed
308.Basnyat, B. Neglected hepatitis E and typhoid vaccines. Lancet 2010; 376: 869.CrossRefGoogle ScholarPubMed
Figure 0

Fig. 1. Morbidity and mortality frequencies in hepatitis E-like epidemics of jaundice or viral hepatitis with pregnancy deaths, 1794–1946. Numerals at end of and alongside bars specify counts. C, Community-based; H, hospital-based. Roman numerals next to names of epidemic location denote class of epidemic according to likelihood of hepatitis E. I, Class I (plausible); II, class II (possible); III, class III (probable). Reference citations: Ludenscheid [8]; Roubaix [9]; St Pierre [1]; Limoges [10]; Paris [3, 7, 11, 12]; St Paul [16]; Heusenstamm [15]; Brisbane [18]; Tennessee [17]; Parma [21]; Bombay [27]; Portoferraio [22]; Piombino [23]; Porto San Giorgio [24]; Soriano nel Cimino [25]; Galeata [26]; Hamet [95]; Istanbul [96, 97]; Tel Aviv [101] and Jerusalem [102].

Figure 1

Table 1. Classification of hepatitis E-like epidemics

Figure 2

Fig. 2. Morbidity and mortality frequencies in hepatitis E-like epidemics of jaundice or viral hepatitis with pregnancy deaths, 1949–1976. Reference citations: Agra [150]; Tunis [108]; Algiers [109]; Haifa [104]; Kazakhstan [29]; Delhi [151]; Gwalior [155]; Pointe-Noire [133]; Rabat [131]; Mecca [262]; Aurungabad [156]; Prizren [145]; Mitrovica [146]; NW Bosnia [147]; Bihac [148]; Gauhati [157]; Tripoli, 1968–1970 [112]; Kathmandu Valley [159]; Pietermaritzburg [144]; Tripoli, 1975 [113] and Ahmedabad [158].

Figure 3

Fig. 3. Morbidity and mortality frequencies in epidemics of hepatitis E-like, ET-NANB hepatitis with pregnancy deaths, 1978–1990. Kashmir Valley [161, 168, 171]; Azamgarh [86]; Calcutta [172]; Vidisha [163]; Medea [122]; Kolhapur [162]; Rangoon [78]; Kathmandu Valley [178]; Tortiya [280]; Rundu [278]; Tashauz [232–234]; S Uzbekistan [78, 235]; Maun [285]; refugee camps, Somalia [284]; refugee camps, Sudan [284]; Karachi [173]; S. Xinjiang [239]; Sulangong [241] and Buldana [174].

Figure 4

Fig. 4. Morbidity and mortality frequencies in serologically-confirmed hepatitis E epidemics with pregnancy deaths, 1987–2010. Kathmandu Valley [179]; Jammu [168]; Kamal [180]; Lower Shibeli region [277]; Sintang [253]; Liboi [285]; Kanpur [164]; Djibouti [81]; Islamabad [176]; Bangui [282]; Darfur [165]; Madi Opei and Palonga [286]; Tongi [166] and Rajshahi [177].